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CHAPTER 1
Introduction
The Rembrandt project “Go with the flow: the heart-brain connection over the life-span”
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The studies described in this thesis were part of a larger project funded by the Rembrandt Institute 
for Cardiovascular Sciences aimed at studying the influence of cardiac functioning on cerebral 
blood flow. This project was executed within two different centers: the Laboratory for Clinical 
Cardiovascular Physiology of the Academic Medical Center (AMC; affiliated with the University 
of Amsterdam) and the C.J. Gorter Center for High-Field MRI, Department of Radiology of the 
Leiden University Medical Center (LUMC). The research described in this thesis was executed as an 
integral part of this joined project and the interested reader is also referred to other publications 
from this project as stated in the list of publications (see: author curriculum vitae). 
519307-L-bw-verbree












The brain is a highly metabolically active organ and although it accounts for a small fraction of 
total body weight (2%), it consumes in the resting condition about 20% of total body oxygen and 
25% of total body glucose [1]. Interestingly, the brain by itself has hardly no capillary recruitment 
and lacks almost any form of energy storage. This requires sufficient and uninterrupted supply 
of blood to the brain and, to this end, it receives ~15% of the cardiac output (amount of blood 
being pumped by the heart in one minute) [2]. Acute interruption of the cerebral blood flow (CBF) 
and with that oxygen delivery to brain tissue, even for a few seconds, has deleterious effects and 
results in loss of consciousness [3]. On the other hand, an increase in CBF to well above normal 
values may elicit (brain tissue) hyperperfusion with formation of edema leading to migraine-like 
headaches, seizures and intracerebral hemorrhage [4]. Therefore, safeguarding the brain from 
respectively, hypo- and hyperperfusion is of major importance. 
The regulation of CBF is complex and comprises of multiple interlinked physiological mechanisms 
including the cerebral autoregulation, chemoregulation, neurogenic regulation and neurovascular 
coupling [5,6]. These mechanisms are largely unique to the cerebral vasculature and act directly on 
the cerebral vascular resistance. The highly effective and seemingly independent CBF regulation 
at the level of the brain itself is often treated as a separate entity [6]. The perfusion of the brain is, 
however, also reliant on a sufficient supply of blood from the heart: acute interruption of CBF due 
to cardiac arrest [7] or by occlusion of a large cerebral artery [8] results in loss of consciousness 
within seconds. Thus, in addition to an effective set of cerebrovascular control mechanisms, 
the function of the heart and the condition of the large brain-feeding arteries are important in 
securing the blood supply to the brain. In other words, CBF is also dependent on factors beyond 
the brain [9]. The idea of considering the cardiovascular system as an integral component of CBF 
control has laid the foundation of the work presented in this thesis and will be discussed into 
more detail in the following paragraphs. 
HEART-BRAIN CONNECTION
The circulation of blood starts with the heart pumping blood through the arteries to the 
tissue under consideration, in this case the brain. To guarantee a sufficient CBF, all elements of 
the circulation need to function properly (and) in concert. Evidence has emerged that cardiac 
dysfunction, impaired vessel patency or a critical reduction in central blood volume each 
may result in insufficient blood supply to the brain [10]. This affects CBF independently from 
cerebrovascular control whereas in turn, insufficient brain perfusion may eventually be followed 
by a decline in cognitive performance [11].
This followed, among others, from observations in patients with chronic heart failure in whom 
a lower CBF [12-14] was associated with a larger prevalence of cognitive dysfunction [15,16]. In 
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a longitudinal analysis, the Framingham Heart Study revealed a similar association between a 
low cardiac output and an increased risk of incident dementia and Alzheimer’s disease [17]. In 
addition, about half of the patients in whom the patency of the large vessels to the brain is affected 
(for instance in carotid artery occlusive disease), have signs and symptoms of mild cognitive 
impairment [18,19]. Reinstitution of cardiac function by a heart transplantation, a left ventricular 
assist device or cardiac resynchronization therapy, improved or restored CBF with beneficial 
effects on cognitive performance [20-25], but the cognitive improvements after extracranial 
shunts remain an open issue [26]. These findings suggest that optimizing blood supply to the 
brain by improving cardiovascular function may become a new preventive or therapeutic target 
for cognitive disorders. Also, a decrease in central blood volume too large to secure cardiac output 
may affect CBF, for example during standing-up. Changing body position from the supine to the 
upright posture leads to a gravity induced shift in blood from the upper body towards the legs 
affecting the return of blood towards the right heart (venous return) [27]. The postural reduction 
in the amount of blood that is directly available to the heart (central blood volume) results in a 
decline in cardiac output with a drop in CBF and CBF velocity. As yet, the current monodisciplinary 
approach from both clinicians and researchers leave the complete heart-brain connection as an 
unexplored territory. A synergy of different expertise fields may provide more insight into the 
interesting and clinically increasingly important relationships between the heart and the brain. 
AIM
From current knowledge on heart-brain interactions, we hypothesize that CBF control involves 
cardiovascular function in addition to the principal regulators of cerebral vessel resistance. 
Disentangling the contributions of systemic versus local brain blood flow regulation is 
challenging and requires expertise from multiple disciplines. At the start of this research project 
we had the good fortune to start a multidisciplinary collaboration and work closely with a MRI 
perfusion expert, a neuroradiologist, a pathologist, and an internist-physiologist sharing our 
special interest in the heart-brain connection. The primary aim of the project “Go with the flow: 
the heart-brain connection over the life-span” is to delineate the human heart-brain connection 
by integrating physiological concepts into the MR-environment and assess CBF and its regulation 
mechanisms at the macrovascular level (using Transcranial Doppler ultrasonography; TCD) and 
tissue level (using arterial spin labeling MR imaging; ASL-MRI). This brought together expertise 
on the characterization of the systemic and cerebrovascular response to physiological challenges 
in health and disease as well as on brain perfusion at the tissue level using high resolution MRI. 
This thesis will mainly focus on the validation and comparison of the two main modalities of this 
project: TCD and ASL-MRI.
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OUTLINE OF THIS THESIS
Chapter 1 introduces and outlines the thesis.
Chapter 2 provides a brief overview of the physiological principles involved in systemic and 
cerebral blood flow control. 
Chapter 3 describes the methods of continuous and non-invasive monitoring of systemic, 
cerebral and pulmonary parameters, followed by a description of the challenges that were used 
to assess autonomic cardio- and cerebrovascular control. 
Chapters 4-6 addresses the validity of cerebral blood flow velocity measurements with transcranial 
Doppler ultrasonography (see methods section 2.1.2) under a variety of circumstances. It has 
thus far been assumed that the diameter of the large intracranial arteries remains unaffected by 
changes in PaCO2 and brain perfusion pressure. Based on this assumption, changes in CBFv are 
considered directly proportional to changes in CBF. However, inconsistent findings in literature do 
not exclude the possibility of diameter changes in large intracranial arteries under the conditions 
of the studies presented in this thesis. Validity of this assumption is therefore relevant for the 
interpretation of data on flow velocity obtained by transcranial Doppler ultrasonography. In 
chapter 4 we investigated the effects of CO2 on the diameter of a large cerebral artery using high 
resolution MRI at 7 Tesla and in chapter 5 the distensibility of this artery driven by systolic-diastolic 
pressure differences. In chapter 6 the effects of sympathetic activity by dynamic handgrip exercise 
on the diameter of a large cerebral artery using high resolution MRI at 7 Tesla. 
Chapter 7 directly compares the CBF tissue response (ASL-MRI) with the CBFv (TCD) response in 
the middle cerebral artery to sympathetic activation by handgrip exercise in the same subject 
population to assess whether velocity changes in a large cerebral artery reflect perfusion changes 
in brain tissue. 
Chapter 8 investigates the influence of cardiac pulsations on pseudo-Continuous ASL (pCASL) 
signal stability.
Chapter 9 summarizes the findings of this thesis and the findings followed by a general discussion 
in chapter 10.
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REGULATION OF SYSTEMIC BLOOD FLOW
In the Rembrandt project, we performed challenges that influenced the systemic blood flow. 
To provide context for the discussion, the next sections describe the basic concepts of systemic 
hemodynamics, cardiac output and cardiovascular control. 
SYSTEMIC HEMODYNAMICS
Hemodynamics are defined as the physical factors and physiological mechanisms that govern 
blood flow. Flow through a vessel follows the laws of mass-equality and inertia, but is simplified 
in steady-state by using the hemodynamic analog of Ohm’s law (generally used to describe 
electrical current). When applied to the cardiovascular system the blood flow is driven by the 
pressure difference between two points along the vessel together with the vascular resistance 
(flow = pressure difference / vascular resistance). Under steady state conditions arterial pressure is 
considered as the driving force behind flow and organ perfusion and is therefore tightly regulated 
[28]. 
The first non-invasive arterial blood pressure device was already invented in 1881 by Von Basch 
[29]. Notwithstanding that the concept of measuring blood flow was already published in 1870 
[30], the measurement of cardiac output, either invasively or non-invasively was not possible 
before the mid of the 20th century. Determination of blood flow, and in particular the flow 
leaving the heart, is considered vital when managing critically ill patients (for instance those with 
severe cardiac or pulmonary disease and/or multi-organ failure). Nowadays, several non-invasive 
techniques (based on rebreathing Fick, Doppler, impedance and finger plethysmography) are 
available to provide real-time and continuous estimates of cardiac output and stroke volume [31]. 
Also MRI quantifies cardiac output in a non-invasive way [32]. In this thesis, we primarily focus on 
blood flow, as the mechanism responsible for the transport of oxygen and nutrients, with blood 
pressure as the driving power behind flow. 
CARDIAC OUTPUT 
The amount of blood leaving the heart in one minute is designated as the cardiac output (CO) 
and equal to left ventricular stroke volume (the amount of blood ejected with each cardiac cycle) 
times heart rate. Stroke volume is dependent upon preload, contractility and afterload. Cardiac 
preload is defined as the amount of blood directly available to the left ventricle and relates to 
thoracic fluid content rather than to central vascular pressures [33]. Therefore, cardiac preload is 
often –also in this thesis– being referred to as ‘central blood volume’. Contractility refers to the 
intrinsic muscle strength of the (left) ventricle independent of its loading condition, and afterload 
refers to the force that opposes ejection of blood out of the ventricle (largely influenced by the 
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aortic impedance, arterial blood pressure and peripheral vascular resistance). Activities of daily 
living such as standing-up and physical exercise but also pathophysiological conditions including 
heart failure and dehydration modify CO by changing one or more of these (extra)cardiac factors 
[34]. 
CARDIOVASCULAR CONTROL
To ensure a continuous and appropriate supply of oxygenated blood to the tissues, the 
cardiovascular system is subject to precise cardiovascular control mechanisms. Although the 
cardiovascular system is under control of both neural and humoral components of the autonomic 
nervous system, in this thesis the focus will be on the neuro-cardiovascular system with the arterial 
baroreflex as its best-known example. The arterial baroreflex is the fastest control mechanism of 
blood pressure and generally acts within seconds [35]. The reflex arc consist of peripheral (stretch) 
receptors embedded in the aortic arch and carotid arteries, afferent pathways (toward the central 
nervous system), pathways within the central nervous system itself, efferent nerves and finally the 
effector organs (e.g. cardiac conductive tissue, cardiac muscle and vascular wall muscle fibers) [36], 
see Figure 2.1). Hence, a fall in arterial pressure leads to reflex adjustments by parasympathetic 
inhibition and sympathetic activation, with an increase in heart rate, in cardiac contractility, and 
in vascular resistance and venous return [37]. Conversely, an increase in arterial pressure results in 
opposite reflex changes. This provides a real-time feedback control on the arterial blood pressure, 
involving the heart as well as the peripheral vasculature. 
Figure 2.1 | Schematic drawing of the afferent and efferent pathways of the baroreceptor reflex arc 
(modified from Wehrwein and Joyner 2013) and a block diagram of baroreflex mediated adjustments 
to a fall in arterial pressure.
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REGULATION OF CEREBRAL BLOOD FLOW 
The regulation of CBF is considered to be independent of the systemic hemodynamics and the 
cerebral control mechanisms maintains CBF more or less constant by adjusting the cerebrovascular 
resistance. Therefore, these regulatory mechanisms provide the “background” to which systemic 
changes in blood flow effect their influence. The mechanisms involved in CBF regulation, i.e. 
cerebral autoregulation (i.e. mechanoregulation), chemoregulation, neurogenic regulation, and 
neurovascular coupling, mechanisms will be discussed in the next few paragraphs. 
CEREBRAL AUTOREGULATION
In the late fifties of the last century, Lassen proposed the ‘classic’ concept of cerebral autoregulation 
(CA) which relates CBF to the cerebral perfusion pressure (CPP) [2]. The CPP is the difference 
between mean arterial blood pressure (MAP) at the base of the brain (i.e. the circle of Willis) 
and intracranial pressure, encompassing cerebral spinal fluid pressure and the central venous 
pressure [38]. The traditional CA curve suggests a constant CBF for a wide range of perfusion 
pressures via adaptations in the cerebrovascular resistance (Figure 2.2) [39]. Beyond the so-called 
pressure limits of regulation (e.g. lower and upper limit), autoregulation is lost and CBF changes 
proportionally to (the change in) MAP. It has been suggested that the lower limit is not a fixed 
value and that it may shift towards a higher MAP in hypertensive subjects [38] and vice versa to 
a lower MAP in patients with orthostatic hypotension related to sympathetic failure [38,40-44]. 
When the cerebral perfusion pressure falls below the lower limit of autoregulation, CBF decreases 
and cerebral ischemia ensues. 
Within the normal physiological range, CA increases or decreases cerebrovascular tone in 
response to changes in CPP using a stretch sensing mechanism of the vascular smooth muscle 
cells (‘the Bayliss myogenic response’ [46]). Stretching of these cells is considered to induce the 
signals that provoke vasoconstriction while reduced transmural pressure leads to vasodilation. 
Although the stretch response is attributed to be a innate property of vascular smooth muscle 
cells [47], the exact underlying signaling pathways are incompletely defined. 
To adapt to the brain’s metabolic demand on CBF in daily life, both fast and slower acting 
components of the CA are required. In the laboratory, static (hours to days) and dynamic (seconds 
to minutes) components of CA can be distinguished in either the time- or frequency domain. The 
dynamic component is assumed to reflect mainly the capacity to counteract the alterations in 
CBF in response to fast changes in blood pressure. This component operates within seconds, and 
represents the response delay of the cerebral vasoregulatory system [48].
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Figure 2.2 | The classical cerebral autoregulation curve describing the pressure-flow 
relationship for the brain. The CBF(v) is controlled to be more or less constant (the so-called 
autoregulatory plateau) via changes in the cerebrovascular resistance. Below and above 
the limits of autoregulation (<60 and >150 mmHg), the brain becomes ‘pressure-passive’ as 
represented by the linear portion of the curve. Modified from Lucas et al. 2010 [45]. 
CHEMOREGULATION
The brain vasculature is extremely sensitive to changes in carbon dioxide partial pressure (PaCO2), 
designated as the cerebrovascular carbon dioxide responsiveness, and in a similar vein to and 
oxygen (PaO2) [49-53]. Lowering vs. elevating the PaCO2 (e.g. hypo- and hypercapnia) causes, 
respectively, vasoconstriction and vasodilatation of the arteries, leading to alterations in CBF. 
Conceptually, chemoregulation operates independently from the CA, but they may have common 
pathways and mechanisms [6,54-58]. The mechanism of chemoregulation is complex has not 
been fully clarified. For long it has been thought that the PaCO2-driven changes in pH modify CBF 
by direct relaxation and contraction of the smooth muscle [59-61]. There is, however, also data 
suggesting that PaCO2 affects CBF both in combination with altered pH and with unaltered pH 
[56] (see for review [61]). 
The sensitivity of CBF to changes in carbon dioxide (CO2) is generally expressed as the percentage 
change per mmHg in PaCO2, and is often quantified non-invasively by relating changes in CBF(v) 
to alterations in end-tidal CO2 [56]. In the normocapnic range, CBFv measured in the middle 
cerebral artery changes approximately 3.5% per mmHg change in end-tidal CO2 [58,62-64]. 
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NEUROGENIC REGULATION
Sympathetic nerves originating from the cervical ganglion abundantly innervate the cerebral 
arteries, but the role of the innervations in CBF control is still under debate [42,65,66]. It is assumed 
that under normal physiological conditions the influence of the central nervous system on CBF 
and its regulation is minor [66]. Increased sympathethic activation during exercise, however, is 
likely to enhance cerebral vascular tone thus counteracting imminent cerebral hyperperfusion 
as a consequence of an excessive increase in BP beyond the cerebral autoregulatory range [67-
70]. Both sympathetic and cholinergic mechanisms are considered important for restricting the 
exercise-induced increase in cerebral perfusion on CBF without affecting the cerebral metabolic 
rate for oxygen (CMRO2) [71,67]. 
NEUROVASCULAR COUPLING
Neuronal activation increases cerebral metabolic demand, i.e. the supply of oxygen and nutrients 
is rapidly adjusted by locally increasing the CBF, as the brain lacks extensive storage for energetic 
compounds [6,5,72-74]. This interplay of supply and demand implies a connection between 
neurons and the local vasculature, to which the term neurovascular coupling was coined. This 
process is probably mediated through the astrocytic end-feet that surround the arterioles [75-78]. 
In response to neuronal activation, elicited for example by a sensory stimulus, the CBF shows 
an overshoot with the supply transiently exceeding the demand, resulting in a local increase in 
oxygenation level. Imaging methods sensitive to either oxygen concentration such as BOLD fMRI 
or to CBF such as SPECT, PET and ASL, apply this principle in order to identify functional regions 
in the brain in relation to specific stimuli (e.g. fMRI). Although neurovascular coupling is often 
portrayed as being independent, interaction with the other regulatory mechanisms is likely, for 
example the local production of CO2. The main distinguishing property of neurovascular coupling 
is the localized nature of this response.
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PARAMETERS
Investigation of the cardio- and cerebrovascular response to physiological stress requires 
(simultaneous) monitoring of systemic, cerebral and respiratory parameters. This chapter provides 
an overview of the parameters that were measured in the studies described in this thesis. 
SYSTEMIC
Blood pressure
Continuous arterial blood pressure (BP) can be measured non-invasively by finger plethys-
mography (Nexfin, Edwards Lifesciences BMEYE, Amsterdam, the Netherlands) using a volume-
clamp technique [79]. The cuff is placed around the midphalanx of the non-dominant hand 
and held at heart level. An optical plethysmograph in the finger cuff measured arterial volume 
continuously. The pressure in the cuff around the finger is adjusted in near real-time (~100 Hz) to 
keep the arterial volume clamped, allowing continuous tracking of the blood pressure. A height 
reference system is placed around a finger next to the cuff and at heart level to account for the 
hydrostatic pressure difference. To estimate changes in BP accurately over time, an automatic 
built-in calibration system (Physiocal) tracks the unloaded diameter of the finger artery to 
keep the arterial unloaded volume constant [80]. The arterial pressure measured at the finger is 
fundamentally different from brachial pressure both in absolute terms (hydrostatic difference) 
and wave shape, such that necessary corrections are applied in the Nexfin system to transform 
finger pressure into brachial pressure [81]. 
In case finger plethysmography is not available (for instance in the MR-environment), BP 
measurements were taken every 2–4 min using an inflatable arm-cuff (Magnitude, In-Vivo, 
Orlando, FL) while HR is continuously monitored by means of an MR-compatible finger pulse-
oximetry unit. 
Heart rate, stroke volume and cardiac output
A pulse contour method (Nexfin CO-trek, Edwards Lifesciences BMEYE, Amsterdam, the 
Netherlands) – adapted for age, sex, height and weight [82] – can provide left ventricular stroke 
volume (SV) and cardiac output (CO; SV multiplied by instantaneous HR). This method has been 
thoroughly validated against invasive thermodilution measurements [82,83]. In our work , Nexfin 
derived CO was validated by means of inert gas rebreathing (Innocor, Innovision A/S, Odense, 
Denmark) [84,85]. The rebreathing method relies on two inert gasses that are inhaled in tracer 
quantities through a bag. The blood-soluble N20 diffuses into the lung capplilaries and the blood 
insoluble NF6 remains in the alveoli and airl. The rate at which the soluble gas disappears from the 












In this thesis, we assessed using two non-invasive modalities the CBF response to a variety of 
physiological challenges. The first modality, transcranial Doppler ultrasonography (TCD), provides 
high temporal resolution assessments of CBF velocity (CBFv) in large brain-feeding arteries. This 
method is a relatively simple and low-cost bedside technique and is assumed to provide accurate 
quantification of the mean CBF over a large area of the brain, that is, the flow territory perfused by 
the insonated artery. The second modality, MRI, provides techniques such as arterial spin labeling 
(ASL) and blood-oxygen-level dependent (BOLD) imaging which enable the measurement of 
whole brain CBF and oxygenation changes at the microvascular level. MRI is a complex, costly 
and time-consuming procedure that offers a non-invasive measure of brain perfusion and 
oxygenation at a high spatial resolution. A combination of TCD and MRI-based quantifications of 
CBF has the potential to complement each other in obtaining a more complete understanding of 
brain perfusion at both the macro- and microvascular level. In the following paragraphs we will 
discuss both modalities into more detail. 
Middle cerebral artery blood flow velocity 
Measuring CBFv in the basal cerebral arteries by TCD was introduced in the early eighties of the 
twentieth century by Aaslid and coworkers [87] and has found wide acceptance in both clinical 
and research settings. The ultrasound probe emits a high-pitched sound wave through the intact 
scull, which is then reflected from erythrocytes moving through ultrasound beam. The CBFv is 
recorded from the Doppler shift spectrum of the reflected sound waves [88]. Mean CBFv reports 
the velocity associated with the maximal frequency of the Doppler shift (“the envelope”), rather 
than the cross-sectional average velocity that defines the blood flow through the artery [89]. The 
average velocity can be obtained from the intensity-weighted mean flow velocity or the total 
signal power, but is sensitive to small changes in insonation angle of the artery [89]. Therefore, the 
maximum velocity is preferred as reported entity.
A TCD system (DWL Multidop X4, Sipplingen, Germany) with a pulsed ultrasound frequency of 
2 MHz can be used to satisfactory penetrate the skull. As the bone of the temporal region is thin 
and therefore the best promising area for ultrasound insonation [87]. CBFv measurements were 
localized in the proximal segments of the left or right middle cerebral artery (MCA). The ultrasound 
probe is placed on the temporal region of the skull just above the zygomatic arch (Figure 3.1). At 
an insonation depth between 45 and 60 mm, the signal is optimized. Subsequently, the probe is 
secured in position by a head-band. 
The relation between calculated vs. actual CBFv depends on angle of insonation [90]. When the 
angle increases from 0° to 30°, its cosine will decrease from 1 to 0.86 resulting in a maximum 
error up to 15% [88]. By immobilizing the probe by a head-band, we minimized the influence 
of a potential change in angle as might occur during the experiments. An important issue of 
TCD whether blood flow velocity accurately reflects the actual underlying blood flow. Changes 
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in blood flow velocity reflect those in blood flow when the cross-sectional area of the insonated 
vessel remains constant (blood flow = blood flow velocity x cross-sectional area). 
Vessel diameter does not change significantly during moderate variations in mean BP or CO2 
tension according to direct observations made during craniotomy [91]. Also orthostatic stress, 
as stimulated by lower body negative pressure (LBNP), does not induce detectable changes in 
the diameter of the MCA as observed with 3 Tesla MRI [92]. These findings suggest that the MCA 
diameter does not change and that changes in TCD-determined CBFv will track those in CBF. In 
three studies presented in chapters 4-6, we examined these assumptions under influence of 
carbon dioxide and sympathetic stimulation using high-resolution MRI at 7 Tesla.
Figure 3.1 | The ultrasound probe is placed on the temporal region of the skull (dotted line indicates the 
‘temporal window’) just above the zygomatic arch A). A frontal view of the ultrasound probe directed 
toward the MCA B). The cilindrical sample volume is indicated by a circle over the MCA, i.e. observation 
region; the distance from the middle of the cylinder to the probe corresponds to the depth setting. 
Reproduced from J Neurosurg [87].
Whole brain blood flow
Since the proposal of ASL two decades ago [93], the non-invasive quantification of regional CBF 
with MRI has progressively developed into a well-accepted and clinically suitable technique. ASL 
MRI is based on the detection of a tracer that is delivered to and cleared from the tissue by blood 
flow [94], and usually expressed in ml/min/100g tissue [95,96]. With ASL, an endogenous tracer is 
created by inverting the proton spins of blood, mainly located in water molecules (H2O). Magnetic 
labeling of arterial blood water spins is done by a long series of radiofrequency pulses (in pseudo-
continuous ALS) that are applied in a plane perpendicular to the neck. Subsequently, labeled 
protons in the arterial blood water act as (almost) freely diffusible tracers. From the labeling 
location the labeled protons migrate within 1–2 seconds via the arterial vessels and capillaries 
into the brain tissue where the label accumulates, thereby altering the local tissue magnetization. 
The change in tissue magnetization is measured by acquiring multiple image slices covering 











not labeled. A 3-dimensional perfusion map can be obtained by subtracting the labeled image 
volume from the control image volume (no label) (Figure 3.2). 
The ASL-signal, i.e. the difference in signal intensity between label and control images, is small 
(~1%). To obtain a sufficient signal-to-noise ratio (SNR), many repetitions of the control and label 
pairs are acquired during 3–5 minutes. The ASL technique applied here is pseudo-continuous 
ASL, as the recommended standard for use in a clinical setting [96] and which has been recently 
compared with 15H2O positron emission tomography (PET) CBF measurements [97]. Background 
suppression RF pulses were used to enhance the SNR of the CBF signal. In addition, the imaging 
module was extended with an extra echo block to obtain the BOLD fMRI signal with minimal 
additional scan time [98]. The BOLD signal is mainly sensitive to the concentration of deoxy-
hemoglobin, and also depends on blood flow, blood volume and tissue properties, such as 
diffusion. This makes this method less specific than ASL. Changes in ASL or BOLD determined 
regional are often used as proxy for neuronal activation [99]. Chapter 7 describes a comparative 
study of the determination of the CBF changes upon small muscle group exercise as measured by 
either ASL MRI or TCD. 
Figure 3.2 | Principle of arterial spin labeling. Arterial blood flowing to the brain is magnetically labeled 
in the neck by applying radiofrequency pulses. The labeled protons (i.e. water in arterial blood) flow 
to the brain tissue, where the labeled water protons mix and accumulate in the extravascular space 
and tissue. To allow the protons to reach the brain tissue, a delay time is applied (i.e. post labeling 
delay, PLD) after which the images are acquired, often with full brain coverage. The static brain tissue 
is subtracted by acquiring a separate set of control images. The control images are obtained without 
labeling the arterial blood. A full brain quantified ASL measurement requires multiple measurements 
of label and control images, and takes 3–5 minutes. 
RESPIRATION
Brain perfusion is highly sensitive to changes in PaCO2 (see section on Chemoregulation). To 
enable a correct interpretation of the CBF and CBFv responses, it is highly recommended to also 
monitor (changes in) PaCO2. The partial pressure of CO2 in exhaled air (designated as end-tidal 
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CO2; PetCO2) is generally used as a non-invasive proxy for PaCO2 and therefore measured in the 
studies described in this thesis. 
Partial end-tidal carbon dioxide pressure
PetCO2 is continuously monitored, via a nasal cannula, by a sampling infrared capnograph 
(Tonocap, Datex-Ohmeda, Madison, USA or Datex Normocap 200, Helsinki, Finland). This technique 
is based upon the absorption of infrared radiation by CO2, with the amount of absorbed radiation 
having a nearly exponential relation to the CO2 concentration. Detecting a change in infrared 
radiation levels, using photo-detectors, allows for the calculation of the CO2 concentration in the 
gas sample. 
Physiological challenges
The present thesis discusses various physiological methods (including orthostatic stress tests, 
small muscle group exercise and inhalation of a gas mixture containing CO2) that were applied to 
address autonomic cardio- and cerebrovascular control. This section summarizes these methods 
with respect to their known physiological mechanism and the way in which they were performed. 
Orthostatic stress tests
Passive head-up tilt (HUT), lower body negative pressure (LBNP) and orthostasis (standing up) all 
lead to a gradual translocation of blood from the intra-thoracic region into the lower parts of the 
body. As a result, CO decreases and a series of cardiovascular regulating mechanisms and reflexes 
come into action to maintain arterial blood pressure and cerebral perfusion. 
Passive head-up tilt
Passive HUT is performed with the subject lying supine and safely strapped on a tilt table (custom 
built by AMC Medical Technological Development / Dr. Kaiser Medizintechnik, Bad Hersfeld, 
Germany) and then either mechanically or manually tilted to a semi-supine (30°), semi-upright 
(45°) and/or almost completely upright (70°) position. Tilting back from 70° HUT to the supine 
position leads to central blood volume repletion and mimics a fluid challenge. 
The bulk blood volume translocates between upper and lower body because the hydrostatic 
indifference point for intravascular pressure (i.e. point in the vascular tree at which pressure 
remains constant independent of body position) is located at the level of the diaphragm [100]. 
Moreover, blood volume measurements by electrical impedance suggest that the indifference 
point for volume as is even lower, positioned between the navel and iliac crest [101,100]. As a 
consequence, in upright position, roughly 70% of the blood volume is located below the level 
[100] of the heart . The translocated blood is mainly being contained in the (compliant) veins and 
venules and, therefore, does not contribute to the effective arterial blood volume [100,102]. This 
shift in blood volume distribution is estimated to be 300–800 ml of which 50% takes place within 











10% or ~500 ml reduction after 5 min and 15% or ~750 ml reduction after another 5 minutes in 
the HUT position [105].
Lower body negative pressure
During LBNP, sub-atmospheric pressure is applied to the lower limbs in a supine subject such 
that blood redistributes from the upper parts of the body into the compliant compartment of the 
lower extremities. In preparation for LBNP, the lower body of the subject is positioned inside an 
LBNP box (Dr. Kaiser Medizintechnik, Bad Hersfeld, Germany / Dept. Instrumental Development, 
LUMC) and sealed at the level of the iliac crest [106]. An advantage of this technique compared to 
passive HUT, is its utilization within the static and horizontal setup of the MRI-scanner.
Standing up
The presumed mechanism behind the gravitational translocation of blood from the intra-thoracic 
region to the veins in the legs during passive HUT is similar to that when humans stand up from 
the supine position. However, the active change in posture during standing-up produces a 
hemodynamic response that is different from what happens with passive tilt during the first 30 s 
of upright posture [107]. 
Small muscle group exercise
Rhythmic handgrip exercise is a form of small muscle group exercise that increases HR and CO, 
with modest changes in blood pressure [108]. An advantage of rhythmic handgripping is that it 
can be performed in the supine position while ensuring minimal (head) motion, which makes 
it a suitable exercise method during MRI monitoring. Moreover, a mild to moderate handgrip 
exercise level can be maintained for a longer period of time to achieve the steady state needed 
for acquisition of ASL-measurements, which typically take about 3–5 minutes. To standardize 
the workload between individuals, the subjects were first instructed to squeeze a handgrip 
dynamometer (fOrb Gripforce, Current Designs Inc., Philadelphia PA, USA) to the maximum 
extent possible for 2–3 s without tensing the entire body. The so-measured maximum force was 
taken as 100%. The exercise experiments consisted of 0.5 Hz intermittent handgrip contractions 
performed for the first minute at 80% of the maximum force followed by 4 minutes at 60%. The 
decreasing force protocol was used to achieve a steady-state in minutes 3 to 5. 
Inhalation of a gas mixture containing CO2 
In order to quantify the cerebral vasomotor reactivity, a wide range of PetCO2 was established 
by, respectively, inhaling a gas mixture containing 5% CO2 and 95% O2 (carbogen) through a 
mouthpiece for 2 minutes, followed by 2 minutes of breathing room air and hyperventilating for 
approximately 2 minutes. 
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ABSTRACT
In the evaluation of cerebrovascular CO2 reactivity measurements, it is often assumed that the 
diameter of the large intracranial arteries insonated by Transcranial Doppler (TCD) remains 
unaffected by changes in arterial CO2 partial pressure. However, the strong cerebral vasodilatory 
capacity of CO2 challenges this assumption, suggesting that there should be some changes 
in diameter, even if very small. Data from previous studies on effects of CO2 on cerebral artery 
diameter (MCA) have been inconsistent. 
In this study, we examined ten healthy subjects (5 female, 5 male, age 21–30 years). High 
resolution (0.2 mm in-plane) MRI scans at 7 Tesla were used for direct observation of the MCA 
diameter during hypocapnia: -1 kPa (-7.5 mmHg), normocapnia: 0 kPa (0 mmHg) and two levels 
of hypercapnia: +1 and +2 kPa (7.5 and 15 mmHg) with respect to baseline. The vessel lumen was 
manually delineated by two independent observers.
The results showed that the MCA diameter increased by 6.8±2.9% in response to 2 kPa PetCO2 
above baseline. However, no significant changes in diameter were observed at the -1kPa 
(-1.2±2.4%), and +1kPa (+1.4±3.2%) levels relative to normocapnia. The non-linear response 
of the MCA diameter to CO2 was fitted as a continuous calibration curve. Cerebral blood flow-
changes measured by TCD could be corrected by this calibration curve using concomitant PetCO2 
measurements. In conclusion, the MCA diameter remains constant during small deviations of the 
end-tidal CO2 pressures from normocapnia, but increases at higher PetCO2 values.
Keywords
Transcranial Doppler; MRI; Hypocapnia; Hypercapnia; Angiography; Cerebral blood flow 
measurement.
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Over the past three decades, Transcranial Doppler (TCD) has been extensively used in clinical 
and research settings for non-invasive assessment of the vasodilatory capacity of the cerebral 
vasculature [1]. The cerebrovascular reactivity, defined as the change in cerebral blood flow 
(CBF) in response to a carbon dioxide (CO2) challenge [2], represents the vasodilatory capacity of 
the cerebral vasculature to changes in arterial CO2 partial pressure. It is often assumed that the 
diameter of the large insonated intracranial arteries remains unaffected by changes in arterial 
CO2 partial pressure [3]. Based on this assumption, changes in blood flow velocity measured with 
TCD in response to a CO2 challenge are considered directly proportional to the change in CBF. 
However, due to the quadratic dependency of the vessel cross-section area on the diameter, even 
small changes in diameter would translate to considerable errors in the measurement of CBF 
changes by TCD. Therefore the validity of this assumption is extremely important.
To test this fundamental assumption, various techniques have been employed to assess the 
effect of substances, such as CO2 and acetazolamide, which are known to change the CBF, on 
the diameter of the middle cerebral artery (MCA). Angiographic studies [4-6] and intraoperative 
measurements [7] of the MCA demonstrated that arteries smaller than the MCA, but not the MCA 
itself, exhibit vasodilation in response to increases in arterial partial pressures of CO2. In contrast, 
comparisons of the blood flow velocity in the MCA with SPECT CBF measurements [8] or venous 
outflow [9] indicated an increase in MCA diameter during administration of CO2. However, these 
methods are indirect measures of the MCA diameter and it is unclear whether the data reflect true 
changes in diameter. Direct observations using MRI-based measurements in conscious humans 
did not show changes in MCA diameter during hypocapnia [3,10] nor during hypercapnia [3]. In 
addition, results from studies with the carbonic anhydrase inhibitor acetazolamide were also 
contradictory. Administration of acetazolamide leads to a decreased pulmonary removal of CO2 
from the blood leading to lower blood pH. One MRI study did not detect an increase in MCA 
diameter following acetazolamide administration [11], while a more recent study did report an 
increase in MCA diameter [12]. In summary, the results from the literature on the effects of arterial 
CO2 partial pressure on MCA diameter are inconsistent.
One explanation for the contradictory findings might be the limited spatial resolution of the 
techniques used in the aforementioned studies in terms of detecting small changes in the MCA 
diameter. Another explanation might be the narrow CO2 range used. 
The purpose of the present study was to measure the MCA diameter for a wide range of end-tidal 
CO2 pressures with high resolution MRI at 7 Tesla and, if changes are present, to use these data to 
construct a calibration curve for TCD-based blood flow velocity measurements. 
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METHODS
Subjects
Ten healthy subjects (5 female, 5 male), aged 21–30 years, were scanned and written informed 
consent was obtained. Subjects refrained from drinking caffeinated beverages and eating for 
at least two hours prior to the experiment. The protocol was approved by the Medical Ethics 
Committee of the Leiden University Medical Center.
Measurements
A gas mixture containing 21% oxygen, 79–71% nitrogen and 0-8% CO2 was administered to the 
subject through a silicone face mask. End-tidal CO2 pressure (PetCO2) was measured through 
a cannula attached to the mask and connected to a capnograph (Capnomac Ultima, Datex, 
Helsinki, Finland) located outside the MRI scanner room. Heart rate and oxygen saturation were 
continuously monitored and blood pressure measurements were taken every 2–4 minutes using 
an inflatable arm-cuff (Magnitude, In-Vivo, Orlando, Florida, USA). 
Protocol
Baseline PetCO2 was measured during 5 minutes of rest inside the MRI scanner. Subsequently, 
four levels of PetCO2 were applied in random order. PetCO2 was varied by inhalation of CO2 and/
or hyperventilation. The target PetCO2 levels consisted of -1 kPa (-7.5 mmHg), 0 kPa (0 mmHg), 
+1 kPa and +2 kPa (+7.5 and +15 mmHg) relative to the subject’s baseline PetCO2. The PetCO2 
was kept constant during the high resolution scans by manually adjusting the CO2 concentration 
of the inspired air [13]. The desired level of PetCO2 was established for at least 30 seconds prior 
to the scan to ensure that a steady state level had been reached before the start of acquisition. 
Subjects were asked to breathe deeply and keep a constant breathing frequency aided by visual 
and auditory stimuli inside the scanner.
MRI acquisition
All experiments were performed on a 7 Tesla whole body Philips Achieva MRI system (Philips 
Healthcare, Best, The Netherlands). The MCA was identified on orthogonally reconstructed axial 
3D T1-weighted scans. The parameters for the 3D T1-weighted were: repetition time / echo time = 
4.1 / 1.84 ms, flip angle = 7°, field-of-view = 246 x 246 x 174 mm3, voxel size = 1 x 1 x 1 mm3, scan 
duration 2 min. The high resolution 2D-scan was planned perpendicular to the MCA and had the 
following parameters: black blood T2-weighted Turbo Spin Echo (TSE), repetition time / echo time 
= 2000/116 ms, refocusing angle = 110°, field-of-view = 240 x 180 x 5 mm3, acquisition matrix 
= 1200 x 900, voxel size = 0.2 x 0.2 x 5 mm3, TSE factor = 12 with additional 4 startup echoes, 
dynamics = 2, total scan duration = 5 min.
Data analysis
Two independent observers (JV & AGTB), blinded to subject and PetCO2 level, manually delineated 
the MCA lumen on the high resolution MRI scan. Within- and between observer agreement was 
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assessed by the Intraclass Correlation Coefficient (ICC2,1, SPSS v20, SPSS Inc., Chicago, Illinois, 
USA). The average value of all observations per vessel was used in subsequent analysis. Data 
analysis was performed offline using MATLAB (vR2012a, Mathworks, Natick, Massachusetts, USA). 
The absolute translation and rotation with respect to the first scan of each subject were assessed 
using the FSL FLIRT routine (v5.0, fMRIB, Oxford, United Kingdom) with three degrees of freedom. 
For each subject the MCA diameter (D) was determined from the lumen area (A), using: π/4AD = . 
Additionally, the lumen area was expressed relative to the lumen area during normocapnia using: 
Anormalized = A/Anormocapnia ·100 %, with Anormocapnia the lumen area during normocapnia. The ΔPetCO2 
was defined for each subject as the absolute difference with respect to normocapnia.
The effect of PetCO2 level on vessel diameter was assessed using a mixed-effects model with 
post-hoc comparisons (SPSS v20, SPSS Inc., Chicago, Illinois, USA). All multiple comparisons were 
Bonferroni-corrected and a p-value less than 0.05 was considered significant.
The normalized vessel area was fitted using a third order polynomial curve and compared to 
a linear model. Goodness-of-fit was assessed with the R-square (R2) statistic adjusted for the 
number of degrees-of-freedom. 
RESULTS
All ten subjects successfully completed the entire protocol and a total of 40 scans were acquired. 
Three subjects reported slight discomfort at +2 kPa, upon which the highest PetCO2 level 
was lowered. In one of these subjects the PetCO2 had to be lowered to values which were not 
appropriate to the study, and this scan was excluded from analysis. One further scan was excluded 
by both observers because of severe motion artefacts at the highest PetCO2 level. The remaining 
38 scans were included in the full analysis.
The effects of PetCO2 on MCA diameter, heart rate and mean arterial pressure are given in Table 
4.1. Four distinct levels of PetCO2 were achieved (p<0.01) with a minor increase in PetCO2 during 
normocapnia compared to baseline (0.17 kPa; p = 0.014). Varying the PetCO2 did not affect heart 
rate (p = 0.187) or mean arterial pressure (p = 0.078). The image quality was sufficient to be able 
to visualize and outline the vessel lumen for all PetCO2 conditions (Figure 4.1). The absolute 
displacements of the head relative to the first scan were 1.6 mm and 2.3 mm in the x and y 
directions, respectively, with a small in-plane rotation of 0.7°. Within-observer agreement was 
very high for both observers, ICC = 0.94 and 0.97 for JV and AGTB respectively. Measurements 
were also consistent between observers, ICC = 0.86, albeit with a significant mean difference of 
0.16 mm (p<0.001, paired t-test).
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Baseline 4.9±0.5 67.5±11.7 81.7±4.7
Hypocapnia 3.19±0.27 3.8±0.5† 69.0±12.9 83.9±7.0
Normocapnia 3.23±0.26 5.1±0.5† 67.1±12.4 83.4±7.0
Mild hypercapnia 3.28±0.33 6.0±0.5† 67.3±12.5 84.1±6.2
Moderate hypercapnia (N=8) 3.42±0.33* 6.8±0.6† 70.2±12.3 88.0±6.3
Data (N=10) are represented as mean ± SD. *p<0.001 vs hypo- (-1 kPa), normo- (+0 kPa), and hypercapnia (-1 kPa). †p<0.001 
vs baseline condition. (Bonferroni-corrected)
Figure 4.1 | Representative example of high resolution MRI scans planned perpendicular to the MCA. 
From left to right: the white square depects the location of the zoomed images; zoomed image at 
hypocapnia (-1 kPa), baseline normocapnia (0 kPa), and hypercapnia (+1 and +2 kPa end-tidal CO2) 
respectively.
Figure 4.2 | Effect of ΔPetCO2 (kPa) on absolute middle cerebral artery diameter (MCA). The ΔPetCO2 
is relative to the subject’s resting baseline in the scanner. Variation in MCA diameter can be observed 
between subjects. Different subjects are indicated with distinct symbol and color.
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There was a significant effect of PetCO2 level on MCA diameter (p<0.001, Figure 4.2) with a 
6.8±2.9% increase in vessel diameter at +2 kPa hypercapnia. No significant differences were 
observed at -1 kPa hypocapnia (-1.2±2.4%), or +1 kPa hypercapnia (+1.4±3.2%) compared to 
normocapnia. The effect of ΔPetCO2 on normalized vessel area is depicted in Figure 4.3. The 
normalized lumen areas for the -1, +1 and +2 kPa PetCO2 levels relative to normocapnia were 
98±5%, 103±6% and 114±6%, respectively. A non-linear PetCO2 – MCA cross-sectional area 
relationship was established using a third-order model (R2adj of 0.51 versus a R
2
adj of 0.44 for a 
linear relation) with the normalized MCA area (y) approximated by: y = 0.93x3 + 1.22x2 + 1.99x + 
99.64, where x denotes ΔPetCO2 in kPa.
Figure 4.3 | Effect of ΔPetCO2 (kPa) on middle cerebral artery (MCA) area relative to normocapnia. The 
MCA area is expressed as a percentage of normocapnia and the ΔPetCO2 is relative to the subject’s 
resting baseline in the scanner. The data is modeled with a 3rd order polynomial (thick-line) and 95% 
confidence interval (dotted-lines). Identical symbols as in Figure 4.2 are used.
Figure 4.4 | Graphical summary of MRI studies directly observing the MCA during CO2 challenges 
[3,10,17]. Data are presented as percentage change in diameter as function of PetCO2 (mean+/-
SEM). Data from Serrador et al. [3] are derived from their Figure 4.3. All studies employed PetCO2 
measurements with exception of Valdueza eta al. [10] that used PaCO2. PaCO2 is comparable to PetCO2 
during hypocapnia [23].
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DISCUSSION
The major finding of the present study is the non-linear behavior of the MCA in response to 
hypercapnia with (proximal) vasodilatation at a PetCO2 level of +2 kPa above normocapnia, 
and constancy of the MCA diameter in the lower PetCO2 range (-1 to +1 kPa). The clinical 
implication is that the often-assumed constant value of the MCA diameter linking TCD blood flow 
velocity measurements to CBF is not valid for PetCO2 levels between +1 and +2 kPa, leading to 
underestimation of the underlying CBF response.
The present data complements those from Serrador et al. [3] by extending the PetCO2 range 
to +2 kPa hypercapnia. Data from the present study confirm their earlier observations that the 
MCA diameter does not change in the lower PetCO2 range up to 1 kPa above baseline. This 
result has also been confirmed using a variety of methodologies, including angiography [4,6,5], 
surgical microscopy [7], TCD [9,14-16] and MRI [3,10]. A recent MRI study by Coverdale et al. [17], 
investigated the MCA diameter response to 6% CO2 inhalation. Whereas the present study 
detected a significant difference in MCA diameter of 6.8% at the highest PetCO2 level (+2kPa), 
they observed an 8% increase at a lower PetCO2 of +1.2 kPa. Moreover, they indicated a significant 
decrease in diameter of -4% during hypocapnia (-1.7 kPa), whereas the present study observed 
a non-significant decrease of -1.2% at a slightly milder hypocapnia level of -1.3 kPa. To reduce 
the subject dependent reaction to a fixed CO2 step (e.g. inhalation of 6% CO2), the present study 
employed controlled PetCO2 levels relative to the baseline of each subject. Together with a 
higher resolution and larger observed mean diameter in the present study this might explain 
the differences in the observed MCA diameter changes between the two studies. Both studies 
used similar subject population and MRI acquisition technique, suggesting strongly that the MCA 
diameter is responsive to PetCO2 levels above +1 kPa. This is in line with a previous observation 
in the +2 kPa PetCO2 range using color Doppler [18], which found an increase in the carotid artery 
diameter, in turn suggesting that the vasoactive effects of PaCO2 are not limited to the smaller 
cerebral arteries [4-7].
In order to place the MCA diameter changes observed in the present study into context, the results 
from the present study and previous literature are graphically depicted in Figure 4.4. Data are 
taken from those studies that directly observed the MCA using MRI [3,10,17]. During hypercapnia 
all studies observed an increased diameter, although this was not statistically significant in all 
studies. During hypocapnia the observations are more variable, suggesting that the diameter 
changes, if present, might be small compared to changes observed during hypercapnia. Based 
on physiological principles, it might be expected that the MCA diameter – PetCO2 relation would 
be sigmoidal [19]. However, an upper and lower bound to the MCA diameter changes are not 
established by the current data.
The cerebrovascular reactivity is defined as the increase in CBF per unit CO2 [2]. Inhalation of 5–6% 
CO2 is a common method to quantify the cerebrovascular reactivity, and increases the PetCO2 
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by 1 to 2 kPa [8,20], with a 3.8%/mmHg increase in CBF in healthy subjects [19]. This implies a 
CBF increase of 57% at +2 kPa, which should be compared to an underestimation of 14% of 
the CBF-change by TCD due to the increase in MCA diameter (6.8%). The accuracy of such TCD 
measurements is diminished if this bias is not accounted for. Clinical guidelines currently do not 
correct for diameter changes at higher levels of PetCO2 and the new data on the PetCO2 – MCA 
diameter relation may be of particular importance for cerebrovascular reactivity measurements 
in a multi-modal setting.
Among the strengths of the present study is the relatively high in-plane resolution of 0.2 mm 
that enabled the detection of a mean increase in MCA diameter of 6.8%. The physical resolution 
of previous studies ranges from 0.27 mm [11] to up 0.7 mm [4,10], which, based on our diameter 
measurements, corresponds to a detection limit of 8.5%–22%. The sensitivity and limited range of 
PetCO2 levels in previous studies may have prevented the detection of small changes in diameter. 
In the present study no changes in MCA diameter between -1 to +1 kPa PetCO2 compared to 
baseline levels were identified. This may well be in agreement with other studies, but we cannot 
exclude that conclusion that the absence of an observed diameter change in the lower PetCO2 
ranges could still be related to technical limitations, such as the spatial resolution of 0.2 mm.
The calibration curve, as presented in Figure 4.3, can directly be related to an over- or 
underestimation of the CBF-change measured by TCD. For practical purposes the non-linear 
relationship between arterial cross-sectional area and PetCO2 was approximated by a third order 
polynomial curve without prior physiological assumptions, enabling the possibility to correct 
TCD measurements by concurrent PetCO2 measurements. This assumes that a smooth fit to all 
available data points best approximates the underlying physiological response, even though 
only at the highest PetCO2 level was a significant difference in MCA diameter found. The variation 
observed between subjects in relative area changes might suggest that the sensitivity to PetCO2 is 
subject-specific. This variation gives rise to the large confidence intervals of the calibration curve. 
Whether (small) MCA diameter changes are of practical value depends on the precision of the 
TCD and PetCO2 measurements and the change in CBF that is considered relevant in a clinical or 
scientific context. Continuous TCD measurements are quite stable during rest, provided that the 
probe is adequately fixed to the head. The uncertainty (standard error of the mean) of TCD flow 
velocity measurements during 3 consecutive 1-minute recordings is, on average, 1% [10 subjects, 
unpublished data]. An underestimate of 1% in the CBF determination, due to the concomitant 
increase in MCA diameter, corresponds to the ΔPetCO2 being higher than +0.4 kPa according to the 
calibration curve. This value should be compared to the typical precision of PetCO2 measurements 
of 0.24 kPa [present study, unpublished data]. At a ΔPetCO2 of +0.4 kPa and a precision of 0.48 kPa 
(2 times standard deviation) the calibration curve gives a 1% uncertainty in the vessel cross-
sectional area. Therefore, without more precise PetCO2 measurements area, changes smaller than 
1% do not improve the accuracy of CBF-changes measured by TCD. However, an underestimation 
of 1% is one order magnitude smaller than the flow-changes expected in clinical practice.
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Several limitations exist in this study. First, the sensitivity of the MRI contrast to in- or outflow of 
blood might affect the apparent diameter of the MCA. In the current study black-blood imaging 
was used, which is inherently dependent on the outflow of blood and gives a complete signal void 
in the vessel lumen when the blood flow velocity is sufficiently high [21]. The use of four startup 
echoes and long echo time further reduces the value of the minimum blood flow velocity for 
which a signal void occurs. Additionally, the observed contrast of the vessel lumen in the present 
study is consistent for all PetCO2 levels. Therefore, it can be assumed that the effect of blood flow 
on the diameter measurements was negligible. It should be noted that some earlier studies [10-
12]used time-of-flight (TOF) imaging to assess the vessel diameter. In TOF imaging the brightness 
and extent of the vessel depends on the inflow of blood [22]. Hence, the apparent diameter of 
the vessel is influenced by the blood flow through the vessel, which is strongly dependent on the 
PetCO2 level. Therefore, black-blood imaging, as used in the current study, should be considered 
more suitable to measure vessel diameter during PetCO2 variation.
During normocapnia and hypercapnia a difference exists between the measured PetCO2 and the 
arterial CO2 partial pressure (PaCO2) [23], which could have introduced some variation in the MCA 
diameter measurements. In a fixed body position, the PetCO2 – PaCO2 relation is linear [23-25] . In 
the present study the subjects remained in the supine position and breathing rate and depth was 
controlled by visual and auditory stimuli. Therefore, a linear relation between PaCO2 and PetCO2 
was assumed. Little or no influence of the PaCO2 – PetCO2 difference is expected on the variability 
of the MCA diameter measurements. In most applications PetCO2 is readily available, making it a 
more suitable parameter for accounting for the effect of CO2 on flow-change measurements by 
TCD.
Subject head-motion between individual scans could introduce errors in the lumen area 
measurements. This motion would lead to a non-perpendicular intersection of the imaging slice 
with the MCA, leading to an overestimation of the lumen area. This study used a 2D-scan planned 
perpendicular to the MCA. Therefore it was not possible to assess the head motion for any out-
of-plane translations and rotations. To estimate the potential impact of such motions, the extent 
of in-plane motion was used as a proxy for the out-of-plane translation and rotations. Limited 
in-plane translation and rotation was observed. Therefore, by extension, overall head motion and 
out-of-plane movement between scans was deemed to be small. Moreover, the image quality 
was consistent between dynamics and only one out of total 40 scans was excluded due to poor 
image quality caused by movement artefacts. Therefore, head motion is considered only a minor 
concern for this study.
This study was performed in a relatively small number (N=10) of young healthy subjects. Increased 
age has been associated with cardiovascular degradation including atherosclerotic changes and 
arterial stiffening [26], which reduces the ability of the arteries to vasoconstrict and vasodilate. 
Therefore, the vasodilatory response of the MCA to CO2 might be reduced in an older population 
compared to the young subjects measured in the present study. This might be one of the 
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explanations for the discrepancy between the results obtained by Schreiber [11] in a population 
with internal carotid stenosis with mean age of 62 years compared to the present study with a 
mean age of 23 years. Finally, only the MCA was considered in the present study. The protocol 
was limited to one artery due to constraints on the total examination time per subject. The MCA 
is a common target for TCD insonation as it supplies a large part of the cerebral hemisphere. It is 
currently unknown whether the observed diameter changes of the MCA could be extrapolated to 
other cerebral arteries, such as the anterior- and posterior cerebral arteries.
CONCLUSION
This study found a non-linear vasodilatory response of the middle cerebral artery diameter under 
hypercapnic conditions. High resolution MR imaging at 7 Tesla in combination with CO2 inhalation 
was able to measure the vasodilatory effect at a PetCO2 level of +2 kPa above baseline, but not 
during -1 kPa (hypocapnia) or +1 kPa (hypercapnia). This indicates that the blood flow velocity 
changes measured with TCD underestimate underlying changes in CBF under high hypercapnic 
conditions. The proposed calibration curve can be used to correct such underestimations of CBF 
changes measured by TCD.
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ABSTRACT
Background: Although cerebral arterial stiffness may be an important marker for cerebrovascular 
health, there is not yet a measurement that accurately reflects the distensibility of major 
intracranial arteries. Herein we aim to non-invasively measure distension of the human middle 
cerebral artery (MCA). 
Methods: Ten healthy volunteers (age: 30.3±10.8 years) underwent ultra-high field (7 Tesla) MRI 
scanning. Time of flight angiography and phase contrast flow imaging were used to locate the 
M1 segment of the middle cerebral artery (MCA) and to determine the occurrence of systole and 
diastole. High resolution cross-sectional cardiac triggered T2-weighted images of the M1 segment 
of the MCA were acquired in systole and diastole.
Results: The average distension of the middle cerebral artery area from diastole to systole 
was 2.58% [min-max range: 0.08%–6.48%]. There was no significant correlation between MCA 
distension and the pulsatility index, calculated from the phase contrast flow velocity profiles. 
Conclusion: These results lead to the first non-invasive image-based estimation of distensibility 
of the MCA (approximately 3 x 10-4 mmHg-1) and demonstrate that ultra-high field MRI could be a 
promising tool for investigating distensibility of intracranial arteries in relation to cerebrovascular 
pathology.
Key words
Arterial Stiffness; Arterial Structure and Compliance; Cerebral Small Vessel Disease; Ultra-high 
field MRI; Middle Cerebral Artery
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Healthy cerebral arteries are able to smooth out the pulsatile blood flow originating from the 
heart into an almost continuous flow into the capillary bed of the brain [1]. If the cerebral arteries 
stiffen, the pulsatile blood flow propagates further into the arterial tree, where the pulsatile shear 
stress can induce damage to the walls of the small vessels [2,3]. This process has been linked to 
severe pathologies, including cerebral small vessel disease (SVD) and vascular cognitive decline 
[2,3], and highlights the potential value of a measure of cerebral arterial stiffness as a marker of 
cerebrovascular health. 
Measuring stiffness (or its inverse: distensibility) in extracranial arteries is commonly done by 
assessing changes in diameter occurring with changes in pressure occurring at the same site 
[4]. The skull complicates such measurements for intracranial arteries, and therefore explains the 
absence of an accurate measurement of cerebral arterial stiffness. However, volume changes of 
approximately 5% occurring throughout the cardiac cycle in the middle cerebral artery (MCA) 
have recently been measured with computed tomography (CT) angiography [5].
In contrast to CT, magnetic resonance imaging (MRI) can be used non-invasively to measure the 
cross-sectional area of the MCA.[6] Based on the volume changes found by CT angiography [5], 
distention of the MCA through the cardiac cycle is expected to be small (0.05–0.1 mm). Non-
invasive imaging of such small geometrical changes requires high resolution measurements, 
which currently is only feasible with ultra-high field MRI [6]. 
In this proof-of-principle experiment we aimed to measure distension of the MCA by using 
ultra-high field MRI and by synchronizing the image acquisition to the cardiac cycle. In addition, 
we assessed the pulsatility index as a combined measure of cerebrovascular resistance and 
stiffness. To the best of our knowledge, this is the first non-invasive assessment of cerebral arterial 
distension in humans. 
MATERIAL AND METHODS
Ten healthy participants were recruited for this experiment (6 females, all non-smoking, average 
age 30.3±10.8 years). Informed consent was obtained from all volunteers. This study was 
performed under approval of the institutional review board of the Leiden University Medical 
Center according to the Declaration of Helsinki and in accordance with the guidelines for Good 
Clinical Practice (CPMP/ICH/135/95).
Image acquisition
MRI scans were performed at 7 Tesla (whole body Philips Achieva, Philips Healthcare, Best, The 
Netherlands) and similar to a previously described protocol[6]. All image acquisition parameters 
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are stated in the online data supplement. A 3-dimensional time-of-flight (TOF) angiogram was 
performed to identify the MCA and for planning of an imaging plane perpendicular to the M1 
segment. Care was taken to select a straight portion of the MCA and exclude branching arteries. 
Planning of this imaging plane was guided by additional reconstructions of the TOF scan to better 
visualize the course of the MCA in all directions. The position and orientation of the imaging 
plane were copied to the quantitative flow scan to assess the flow velocity waveform through the 
MCA. Directly after acquisition, a circular region of interest in the centre of the MCA was used to 
determine to flow velocity profile at the level of M1, which was used to determine the time points 
at which peak-diastole and peak-systole occurred and to calculate the post-trigger acquisition 
delay times for the cardiac triggered T2-weighted images. High resolution and cardiac triggered 
T2-weighted images were acquired at 4 time points in the cardiac cycle in pseudo-random order: 
200 (t1) and 100ms (t2) preceding peak-diastole, and 50 ms before (t3) and 50 ms after (t4) peak-
systole. These time points were chosen because in the carotid artery peak flow velocities have 
been shown to closely follow systolic and diastolic pressure [7]. An example of a high resolution 
structural image can be seen in Figure 5.1a. Throughout all scans pulse oximetry at the finger was 






















Figure 5.1 | A. Example of T2-weighted high-resolution structural image of the cross-sectional area of 
the M1 segment of the MCA. B. Example of phase contrast flow velocity data (dots) measured at the 
same location as A. The flow velocity waveform was approximated by fitting the first five harmonics of 
a Fourier sequence (solid line), from which the pulsatility index was calculated. MCA = middle cerebral 
artery, Sys = systole, Dia = diastole.
Image analysis
Two observers, blinded to participant and cardiac phase of the images, manually drew elliptical 
regions of interests on the T2-weighted images to delineate the internal wall of the MCA. Each 
observer repeated this process once, and the average of all 8 measurements (two scans per time 
point and two observers who delineated the MCA twice) per time point was used to calculate MCA 
cross-sectional area. Paired t-tests were used to investigate whether the MCA area at time points 
t1, t3, and t4 were significantly different than at t2 (triggered closest to peak-diastolic velocity). 
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To investigate the consistency within and between observers the intraclass coefficient of 
correlation for consistency (ICC(C,1), ICC(C,k)) was calculated with Matlab (R2012b, MathWorks, 
Natick, Massachusetts, USA). 
The quantitative flow scan was also used to calculate a commonly used cerebral arterial stiffness 
index based on the blood flow velocity waveform through the MCA, the pulsatility index (PI) [8]. A 
linear regression was performed (robustfit in Matlab) between the distention of the MCA between 
peak-diastole and peak-systole (t2 and t3) and the PI.
RESULTS
There was high consistency in MCA area measurements within observer (ICC(C,1)Obs.1 = 0.89, 
ICC(C,1)Obs.2 = 0.92) and between observers (ICC(C,k) = 0.91), justifying the averaging of all 8 MCA 
area measurements per time point. 
There was a significant increase in MCA area between diastole and systole of 2.58% [min-max 
range: 0.08%–6.48%] (t-test, p<0.01), see Figure 5.2a. 
The group average PI was 0.80 ± 0.12, and was not significantly correlated with the change in 
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Figure 5.2 | A. Group average (N = 10) cross-sectional area of the MCA for 4 different delay times. Data 
was normalized per participant by dividing by the average MCA cross-sectional area of each individual. 
Note that t2 is the delay time closest to peak-diastole and t3 the delay time closest to peak-systole. 
There was a significant difference (* p<0.05, paired t-test) between the diastolic and systolic area. 
The errorbars indicate the standard error of the mean. B. The increase in area from diastole to systole 
plotted against the pulsatility index for all 10 participants. (No significant correlation, r2 = 0.13, p = 0.35). 
MCA = middle cerebral artery.
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DISCUSSION
In the current study it is shown for the first time that ultra-high field MRI can be used to non-
invasively measure distention of the MCA occurring through the cardiac cycle, which is a 
prerequisite for measurement of cerebral arterial stiffness. When combined with reference values 
for central pulse pressure in healthy participants (45 mmHg [9]), the estimated average MCA 
distensibility is approximately 3.0 x 10-4 mmHg-1.
This level of distensibility in the MCA is plausible, as the significant change in MCA area of 
2.58%±2.4% through the cardiac cycle falls within the range of volume changes in the MCA 
measured with CT.[5] Furthermore, the resulting estimation of MCA distensibility follows the 
expectation that intracranial arteries are less distensible than extracranial arteries, e.g. reported 
distensibility in the carotid artery ranges from 0.5 x 10-3 to 5.8 x 10-3 mmHg-1 [4]. 
There was no correlation between the distention of the MCA cross-sectional area and PI. 
Although in a small cohort, this finding highlights that in addition to local arterial stiffness, other 
factors such as stiffness and resistance of the downstream vascular bed shape the blood flow 
velocity waveform [10]. Furthermore, this illustrates the need for investigation of the relationship 
between cerebral arterial distensibility and the formation of blood flow velocity waveforms, 
which is an important step in understanding the mechanisms that link increased arterial stiffness 
to cerebrovascular pathologies, such as SVD [11] and vascular cognitive decline [3]. Future studies 
investigating these mechanisms should include participants with a wide range of expected 
cerebral arterial distensibilities, e.g. young and elderly individuals or patients with SVD. 
A limitation of this study is that no blood pressure measurements were included and therefore 
only an estimation of MCA distensibility was feasible. However, underlying pulse pressures are 
not expected to show large deviations from reference values [9], because only healthy and non-
smoking volunteers were recruited. Future work should include blood pressure measurements, 
such that cerebral arterial stiffness can be quantified in terms of distensibility or compliance 
[1,12]. Although measuring local pulse pressure would be a requirement for accurate estimation 
of arterial distensibility [4], we recommend using a non-invasive measurement of blood pressure 
(e.g. brachial blood pressure [12]) in studies for which it is not feasible to invasively assess 
intracranial blood pressure.
In summary, we have shown that ultra-high field MRI can be used to non-invasively measure 
cerebral arterial distensibility and that this is a promising tool for future research into the 
relationship between cerebral arterial stiffness and cerebrovascular pathology.
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ABSTRACT
Transcranial Doppler sonography (TCD) is a frequently employed technique for quantifying 
cerebral blood flow by assuming a constant arterial diameter. Given that exercise increases arterial 
pressure by sympathetic activation, we hypothesized that exercise might induce a change in the 
diameter of large cerebral arteries. Middle cerebral artery (MCA) cross-sectional area was assessed 
in response to handgrip exercise by direct MRI observations. 20 healthy subjects (11 female) 
performed three 5 minutes bouts of rhythmic handgrip exercise at 60% maximum voluntary 
contraction, alternated with 5 minutes of rest. High-resolution 7-Tesla MRI scans were acquired 
perpendicular to the MCA. Two blinded observers manually determined the MCA cross-sectional 
area. Sufficient image quality was obtained in 101 MCA-scans of 19 subjects (age-range 20–59 
years). Mixed Effects modeling showed that the MCA cross-sectional area decreased by 2.1±0.8% 
(p = 0.01) during handgrip, while the heart rate increased by 11±2% (p<0.001) at constant 
end-tidal CO2 (p = 0.10). In conclusion, the present study showed a 2% decrease in MCA cross-
sectional area during rhythmic handgrip exercise. This further strengthens the current concept of 
sympathetic control of large cerebral arteries, showing in-vivo vasoconstriction during exercise-
induced sympathetic activation. Moreover, care must be taken when interpreting TCD exercise 
studies as diameter constancy cannot be assumed.
Keywords
Transcranial Doppler; Exercise; Cerebral Blood Flow; MRI; MR Angiography; Cerebral Blood Flow 
Measurement. 
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The regulation of cerebral blood flow (CBF) is critical for the maintenance of oxygen and nutrient 
supply to the metabolically active brain. CBF control is multifactorial, influenced largely by the 
partial pressure of arterial carbon dioxide, mean arterial pressure and cerebral metabolism [1]. 
Despite the abundance of sympathetic nerve fibers emanating from the cervical and stellate 
ganglia that innervate the cerebral arteries, the role of the autonomic nervous system in the 
control of cerebral blood flow (CBF) in humans has remained contentious for decades [2-10]. 
In peripheral circulations arterioles rather than large arteries are the main site of vascular 
resistance. However, for the brain, large vessels contribute ~50% to vascular resistance [11]. This 
noticeable contribution of large arteries in vascular resistance is most likely of importance in 
defending the cerebral microcirculation against surges in blood pressure by limiting fluctuations 
in microcirculatory pressure and cerebral perfusion [12-14]. Several observations have been put 
forward as an argument for sympathetic influence on the human cerebral vasculature [6,15]. At 
first, blocking sympathetic outflow to the human cerebral vasculature increases CBF, suggesting 
a sympathetically mediated restraint of cerebrovascular perfusion [15]. Second, systemic agents 
that impair sympathetic signaling (alpha-adrenergic) reduce measures of cerebral pressure 
autoregulation [15,16]. Finally, in healthy subjects, spillover of sympathetic neurotransmitters in 
the jugular vein is increased during sympathetic activation independently from neurotransmitters 
released in the brain [17]. These observations suggest that the cerebral vasculature is under 
sympathetic control, leaving the challenge to identify changes in human brain artery diameter 
during sympathetic activation, especially when these would impact interpretation of physiological 
measurements, such as Transcranial Doppler (TCD).
In humans, changes in CBF are commonly evaluated non-invasively by measuring the CBF-
velocity (CBFv) by transcranial Doppler sonography (TCD) in the large cerebral arteries with 
real-time resolution [18]. A limitation of the majority of studies is that a constant diameter of the 
insonated brain artery is assumed to directly link changes in CBFv to changes in regional CBF. This 
assumption of constancy of brain artery diameter has been evidenced to be violated by high levels 
of PaCO2 [19,20] and pressure pulsatility [21,22], but it is as yet unknown whether the assumed 
constancy of brain artery diameter holds true during exercise. Given that functional activation 
increases CBF and that sympathetic activation and arterial pressure increase with exercise, we 
hypothesized that exercise affects the diameter of large cerebral arteries. To that purpose we set 
out to quantify the middle cerebral artery (MCA) cross-sectional area in rest and in response to 
rhythmic handgrip exercise using high resolution 7 Tesla MRI. 
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MATERIALS AND METHODS
Subjects 
Twenty healthy, non-smoking, non-diabetic, right handed subjects (9 males, 11 females) 
without history of cardiovascular disease underwent MRI during rhythmic handgrip exercise. No 
information about the active or chronic use of vasoactive medication or painkillers was obtained. 
One subject used a beta-adrenergic blocking agent for mild hypertension which was considered 
not to have an effect on the cardiovascular response to handgrip exercise [23]. Written informed 
consent was obtained from all participants prior to examination. The protocol was performed in 
accordance with the Helsinki protocol, as approved by the institutional Medical Ethics Committee 
of the Leiden University Medical Center.
Measurements
MRI measurements were performed on a 7 Tesla Philips MRI system. Image acquisition parameters 
have been described previously [24] and are listed in Table  6.1. The MCA contralateral to the 
exercise hand was located on an orthogonally reconstructed axial Time-Of-Flight angiogram. 
Additional sagittal reconstruction was created along the course of the MCA to aid the planning 
procedure. Subsequently, the high resolution 2D scan based on the black-blood approach and 
with a voxel-size of 0.2 × 0.2 × 5 mm3 was positioned perpendicular to the MCA. This scan will 
be referred to as “MCA-scan” for the remainder of this article. Care was taken to select a straight 
part of the proximal MCA and exclude small branches whenever possible. Image blurring due to 
variations in vessel lumen across the cardiac cycle was minimized by prospectively triggering the 
acquisition to the subject’s heart beat using the finger pulse-oximetry unit of the scanner [22]. 
Acquisition duration was 2.5 to 3.5 minutes, depending on the heart rate (HR) of the subject. End-
tidal CO2 (PetCO2) was continuously monitored via a nasal cannula connected to a capnograph 
(Capnomac Ultima, Datex), located in the control room adjacent to the scanner. Heart rate (HR) 
was obtained from the finger pulse-oximetry unit of the MRI scanner. After 10–15 minutes of 
preparatory scans, a brachial blood pressure measurement was performed on the right arm 
(Invivo Magnitude, Orlando, FL). 
Protocol
A graphical representation of the protocol is illustrated in Figure 6.1. Exercise consisted of 
5 minutes of dynamic handgripping, i.e. repeated 2 sec hand contractions alternated with 2 sec 
of relaxation. Prior to scanning the subjects were familiarized with the protocol and handgrip-
device (Gripforce 500N, Curdes, Philadelphia PA, USA). Maximum voluntary contraction (MVC) of 
the dominant hand was assessed by taking the maximum of 3 attempts. To achieve and maintain 
a steady state, rhythmic handgrip started the first minute at 80% MVC to be directly followed by 
60% MVC for 4 minutes. Pilot-studies proofed that this approach results in a robust and steady 
response for the complete duration of the exercise bout. Graphical representations of the imposed 
exercise rhythm as well as the force applied by the volunteer were displayed onto a screen in the 
scanner to provide visual feedback to the subject. The exercise protocol started with 5 minutes of 
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rest followed by 5 minutes of handgrip. This was repeated three times to facilitate the detection 
of small differences in cross-sectional area. Acquisition of the MCA-scan was started 90 seconds 
after start of the rest or exercise bout. A total of 6 MCA scans (3 at rest and 3 during exercise) were 
obtained per subject.
Table 6.1 | MRI scan parameters.
Time-of-Flight Angiogram Black blood T2-weighted (MCA-scan)
Planning orientation 3D acquisition covering the circle of Willis Single slice, perpendicular to the MCA
Scan Technique Fast Field Echo Spin Echo
Acceleration type none Turbo spin echo; factor 12 + 4 dummy
Repetition time/echo time 12.6 / 3.7 ms 2 heart beats / 86 ms
Flip/ Refocusing angle 20° / – 110° / 105°
Field of view 180 x 170 x 40 mm3 240 x 180 x 5 mm3
Acquisition matrix 544 x 540 1200 x 900
Scan duration 4 min 2.5–3.5 min, depending on heart rate
Additional parameters – Trigger delay 50ms
The time-of-Flight angiogram was used to locate the MCA and additional reconstructions ensured perpendicular planning 










Figure 6.1 | Graphical representation of the exercise protocol. Relative timing of the MCA-scan is 
indicated by the gray area and the relative force level by a dashed line.
Data processing
The MCA-scans were anonymized and viewed in proprietary Philips viewing software. Two 
observers blinded to subject-number and condition (JV, AGTB) manually drew elliptical regions 
of interests to determine the MCA cross-sectional area twice. Quality of the MCA-scans was 
visually assessed, and scans with visible motion artefacts or a badly discernable vessel wall were 
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excluded from analysis. All PetCO2 recordings and HR data were visually inspected and artifacts 
were manually removed. Values during rest and exercise were averaged per subject. Relative 
(percentage) change was calculated by normalizing with respect to the resting condition: relative 
= 100% · (handgrip–rest) / rest.
Statistics
The Intraclass Correlation Coefficient assessed the consistency within- and between observers 
(ICC C-k, SPSS v23). The effect of handgrip was assessed with a Mixed-effect model (Statistics 
Toolbox, Matlab v2015b) taking the percentage change in vessel cross-sectional area, HR and 
PetCO2 as dependent variable. A fixed intercept with subjects as random intercept was used 
to model the change in cross-sectional area. The possible effects of time, age, and gender and 
change in PetCO2 on the cross-sectional area change were investigated in separate models, using 
a fixed effect analysis. Normality of the residuals was assessed using Lilliefors test. Based on a 
sample-variance of 8.19±1.32 mm2 as measured during normocapnia in a previous study [19], 
the a-priori power was set to 0.9 to detect a difference of 5% in cross-sectional area resulting in 
a sample size of n = 20. Significance threshold was set at 0.05. Values are mean±SE except when 
stated otherwise.
RESULTS
Sufficient image quality was achieved in 101 of 120 scans, such that 19 subjects entered final 
analysis. The median (range) age was 30 (20–59) years and resting systolic- and diastolic arterial 
pressures were 112±9 and 69±10 mmHg (mean±SD) respectively.
During exercise HR increased 11.2±1.7% (p<0.001), without change in PetCO2 (-0.9±0.5%, p<0.10, 
see Table 6.2). 




(mean ± SD)  
Effect Estimate 
(mean ± SE)
Area (mm2) 7.47±1.18 7.31±1.15 -2.1±0.81% p = 0.01
HR (bpm) 62.0±12.5 68.4±12.5 11.2±1.7% p<0.001
PetCO2 (kPa) 5.06±0.36 5.02±0.36 -0.9±0.5% p = 0.10
Fixed effect estimates determined by corresponding Mixed Effects model. Area: cross-sectional area of the middle cerebral 
artery; HR: heart rate; PetCO2: end-tidal carbon dioxide.
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Both the consistency of MCA area measurements within- (ICC A-k = 0.978 and 0.977 for JV and 
AGTB respectively) and between observers (ICC C-k = 0.981) were considered sufficient to accept 
the reliability of the average MCA cross-sectional area measurement. A representative example of 
the image quality of the MCA-scan is depicted in Figure 6.2.
Figure 6.2 | Example of a high resolution cardiac triggered MRI scan of the MCA; based on the black 
blood principle. The white box indicates the zoomed area showing the lumen of the MCA.
The mean cross-sectional area during rest was 7.47±1.18 mm2 (diameter of 3.1 mm), which 
decreased during handgrip exercise by 0.16 mm2 to 7.31±1.15 mm2, see Figure 6.3. The change 
in cross-sectional area was -2.11±0.81% (95% confidence interval: -3.74%, -0.49%, p = 0.01), see 
Figure 6.4, corresponding to a decrease in diameter of 1.1±0.4% (0.033 mm). Repeated exercise 
challenges (time-effect) did not have an effect on this relation (p = 0.07).
The age of the participants was strongly clustered into two groups. Therefore, the effect of age 
was assessed by splitting the population into a group below- (3 males, 8 females) and above 
40 years of age (5 males, 3 females). There was no relation between age and the change in cross-
sectional area in response to exercise (p = 0.76). The change in PetCO2 did not have a relation to 
the change in cross-sectional area (p = 0.51). There was a larger reduction in cross-sectional area 
in males compared to females (βmale = -3.46±1.47, p = 0.02). 
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Figure 6.3 | Effect of dynamic handgrip exercise on the average MCA cross-sectional area. Black error-
bars indicate mean and standard deviation. Squares represent males and circles females. Corresponding 
measurements of a subject are connected by a line. * p<0.05 rest vs. handgrip.


















Figure 6.4 | Scatterplot of the cross-sectional area during rest and handgrip. All 57 data pairs are 
plotted for male (square) and female (circle) subjects. The Mixed Model Estimate is indicated by the 
dotted line with 95% confidence intervals (dashed lines). The line of identify (dotted line) is added for 
visual reference.
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The main finding of the present study is that a 2% reduction in the contralateral MCA cross-
sectional area in response to rhythmic handgrip. This suggests that vasoconstriction occurs in 
a large brain artery during exercise induced sympathetic activation. This falsifies the hitherto 
assumed constancy of cerebral artery diameter.
Regarding the evaluation of cerebral perfusion with TCD, the concern has been raised whether 
the diameter of the basal cerebral arteries remains constant during sympathetic activation, 
specifically exercise [8,9,25]. To our knowledge this is the first study to directly observe a MCA 
lumen change during exercise with high resolution MRI. To date a single study estimated the 
change in MCA cross-sectional area specifically during rhythmic handgrip [8]. Their estimate of 
21% change was indirect, i.e. by comparing the regular TCD signal with the spectrally averaged 
Doppler signal, and therefore not easily comparable with the present findings. A study, assessing 
the effect of sympathetic activation on arterial diameter did not find a change in a small peripheral 
artery of the foot as assessed with ultrasound [7]. Moreover, direct MRI observations of the MCA 
during sympathetic stimulation by lower body negative pressure [26] also did not find a diameter 
change. The absence of observable changes in these studies suggest that, the magnitude of 
any changes can be considered minor. Moreover, changes in MCA cross-sectional during CO2 
inhalation and pressure pulsatility can also be considered small [19,20,22]. This is in line with the 
current finding of 2% vasoconstriction, indicate that MCA cross-sectional area changes are small 
when induced by sympathetic activation by moderate exercise. 
The extent in MCA diameter response to exercise and sympathetic activation could differ 
depending on factors such as age and gender. Findings of the present study suggest a larger 
change in MCA cross-sectional area in males compared to females in response to rhythmic 
handgrip. Thisfinding coincides with the observation that premenopausal females exhibit lower 
sympathetic outflow in response to static handgrip exercise [27] and lower cerebrovascular 
reactivity [28,29] as a marker for brain vessel dilatory capacity. Contrary, with age, no relation 
with the degree of MCA vasoconstriction was observed in present study. This is in line with 
preserved sympathetic response to autonomic challenges [30,31] and preserved carbon dioxide 
cerebrovascular reactivity [32,33] in aging. We consider that the limited sample size of the gender 
and age groups precludes proper inference of possible differences.
Small changes in vessel lumen can have profound influence on the estimation of CBF by relative 
velocity measurements. A decrease in vessel lumen proportionally increases the flow velocity even 
at constant blood flow. However, with exercise both the lumen and blood flow and are changing. 
For example, during handgrip the CBFv increases from 50 cm/s to 55 cm/s, corresponding to an 
apparent 10% increase in CBF. However, a concurrent decrease in cross-sectional area of 2.1% 
reduces the underlying CBF change to 7.9% rather than the 10%, as would be estimated from 
the velocity only. Moreover, the variation in the cross-sectional area change ranged (mean±STD) 
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from -10.4±4.7% (subject 3, male, n = 3) to 4.3±5.3% (subject 16, female, n = 2), respectively 
overestimating and underestimating the underlying CBF response to handgrip exercise by 10.5% 
and by 5.3% in these subjects. Given a measured 10% change in velocity, the corresponding 
change in CBF, corrected for the change in lumen area of these subjects, would be +0.5% and 
+15.3%, respectively. While the change in lumen seems slight, it constitutes a sizable part of the 
TCD determined cerebral hemodynamic response during handgrip exercise.
Measuring small changes in vessel lumen requires high precision measurements. The acquisition 
resolution of the employed MCA-scan was 0.2 x 0.2 mm2, therefore the average change in MCA 
cross-sectional area of 0.16 mm2 constitutes ~4 pixels, providing for sufficient statistical power 
in the current study to infer these changes. The determination of the cross-sectional area can 
be dependent on the effective contrast of the acquisition as well as on the observer accuracy. 
Reliability of the cross-sectional area assessments was augmented by excluding scans with poorly 
discernable MCA vessel wall (e.g. subject motion), as well as by averaging the observations of two 
observers, who were blinded to participant number and condition.
High resolution scanning was complemented with cardiac triggering that stabilized the imaging 
by timing the acquisition with respect to the cardiac cycle. Although this approach prolongs 
scan time, it mitigates blurring effects and imaging artifacts. In addition, the sensitivity of the 
MCA-scan to variations in blood flow has been minimized by the application of dummy echoes, 
thereby creating a clear signal void within the vessel lumen [19]. Although some dependency of 
the intravascular signal on the blood flow velocity may persist, an increase in flow velocity near 
the vessel wall would make the lumen appear larger rather than smaller. This effect can therefore 
not explain the observed decrease in cross-sectional area as found in the current study, it might 
only have resulted in an underestimation of the actual decrease in MCA cross-sectional area.
A potential limitation of the present study is the application of concurrent visual feedback to 
maintain the desired exercise level. Stimulation of the visual cortex by the visual feedback is 
associated regional increases in CBF [34]. However, the visual cortex is supplied by the posterior 
cerebral circulation rather than by the MCA, rendering an effect of visual stimulation on the 
MCA cross-sectional area negligible. Another limitation of the present study is that the level of 
sympathetic activation was not directly determined. This could have contributed to the large 
between-subject variation. However, the exercise protocol was setup to provide a consistent 
response within- and between-subjects, by scaling the prescribed force to the individually 
maximal voluntary contraction. Currently no data exist how the level of (rhythmic handgrip) 
exercise impacts sympathetic activation, and we can therefore not exclude an effect of the level 
of sympathetic activation on the large between-subject variation. In the present study arterial 
pressure was not monitored during exercise, as brachial pressure measurements would occlude 
either the handgripping arm or disrupt blood flow in the finger used for triggering the MCA-scan. 
However, it has been well documented that the arterial pressure increases in response to rhythmic 
handgrip exercise [35,36]. This increase in pressure is required to provide the work to counteract 
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the higher vascular resistance and actually increase the blood flow velocity. Without an increase 
in pressure the blood flow would decrease with a constant flow velocity. Therefore, given that the 
arterial pressure increases during handgrip exercise, then the observed vasoconstriction in the 
MCA can be considered to modulate the blood flow velocity and lead to an overestimation when 
using TCD to assess CBF changes. 
CONCLUSION
In conclusion, the present study observed a 2% decrease in MCA cross-sectional area with MRI 
during rhythmic handgrip exercise in healthy subjects. This further strengthens the current 
concept of sympathetic control of large cerebral arteries, showing in-vivo vasoconstriction during 
exercise induced sympathetic activation. Finally, the assumption of constancy vessel diameter 
is falsified. Therefore, care must be taken when interpreting TCD measurements of the cerebral 
circulation in exercise studies. 
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ABSTRACT
Changes in Transcranial Doppler (TCD) determined cerebral blood flow velocity (CBFv) are 
regularly considered to reflect (proportional) changes in cerebral blood flow (CBF), for instance 
during exercise. However, neuroimaging studies indicated a localized and smaller CBF increase 
compared to the CBFv changes. The aim of this study was to validate this interpretation by 
comparing the TCD measured velocity response to rhythmic handgrip exercise with the regional 
CBF response assessed with Arterial Spin Labeling (ASL) MRI. Thirty-eight healthy subjects 
completed an exercise protocol of three times 5 minutes of rhythmic handgrip. In the first session, 
the cerebral hemodynamic response to handgrip was assessed by TCD and during the second 
session by ASL-MRI. No difference in heart-rate response was observed between TCD and MRI 
sessions and PetCO2 remained unchanged. During handgrip CBFv increased by 10.7±11.7%, 
whereas no change in CBF in the MCA flow territory was detected by ASL MRI (-1.2±10.4%, 
p = 0.18); regional CBF increased by 7.8±10.1% in the precentral region. Therefore, changes in 
CBFv do not reflect changes in the underlying flow territory CBF and/or regional CBF. These 
findings call into question the nature or the disparity between large artery flow velocity and brain 
tissue flow in response to rhythmic handgrip.
Keywords
Arterial spin labeling; cerebral blood flow; rhythmic handgrip; MRI; transcranial Doppler
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During exercise the brain is activated [1-3], and locally enhanced neuronal activity and energy 
demand [4,5] increase cerebral blood flow (CBF) in specific areas of the brain [6-8]. Transcranial 
Doppler (TCD) determined cerebral blood flow velocity (CBFv) in large brain-feeding arteries is 
commonly used as proxy for CBF [9]. During dynamic exercise with large muscle groups (e.g. cycling 
exercise) CBFv varies in parallel with 133Xe clearance measures of CBF [10,11], with Fick-determined 
CBF [12], and with internal [13,14] and common carotid artery flow [15]. In contrast, high spatial 
resolution neuroimaging studies evidenced that upon static handgrip [16,17], rhythmic handgrip 
[18] and cycling [19-21] increases CBF in specific cortical regions only. This increase in regional CBF 
(rCBF) occurs in only a small sub-region of the flow territory of the artery in which TCD measures 
the velocity. The much smaller volume sub-region involved in neuronal activation during exercise 
suggests that the change in flow territory CBF (ftCBF) is much smaller than the CBFv increase in 
large brain arteries. 
For example, the CBF change upon mild to moderate exercise of 10–15% [17-19] is limited to 
the motor cortex, which comprises only 3% of the entire MCA flow territory [22]. Combining 
these numbers suggests that the ftCBF increases by 0.3–0.5%. However, TCD observations during 
dynamic handgrip exercise showed that MCAv increases by 8–19% [23-31]. Depending on the 
location of measurement either the ftCBF increases negligible (<1%) using spatially resolved CBF 
or substantial (~10%) when assessed with CBFv. We therefore question whether CBFv is a valid 
proxy for CBF during small muscle group exercise. This study addressed whether the increase in 
CBFv during exercise matches the CBF-change within the corresponding flow territory or within 
the activated brain region. To that purpose the study compared CBFv and MRI-determined CBF in 
healthy subjects during dynamic handgrip exercise. 
MATERIALS AND METHODS
Subjects
57 non-smoking subjects were included in the study. The study was performed in accordance with 
the Helsinki protocol, as approved by the institutional Medical Ethics Committee of the Academic 
Medical Center in Amsterdam. Written informed consent was obtained from all participants prior 
to the medical screening. All subjects underwent a medical screening on a separate day prior 
to the experiment consisting of a medical interview, fasting blood sampling (including plasma 
hemoglobin, hematocrit, HbA1C, creatinine, glucose, total-, HDL- and LDL-cholesterol), urine-
testing and a 12-lead electrocardiogram (ECG). Subjects were excluded from participation in case 
of cardiovascular disease, hypertension, diabetes mellitus and/or neurological disease, use of 
vasoactive medication, abnormal lab-results, abnormal ECG and/or smoking or having smoked 
<10 years ago. Subjects were instructed to abstain from alcoholic and caffeinated beverages for 
at least 4 hours prior to the experiment. 
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Sessions
All subjects performed the same exercise protocol in two measurement sessions in fixed order, 
separated by 8±4 days. During the first (TCD) session, continuous CBFv, non-invasive blood 
pressure (BP), heart rate (HR) and end-tidal CO2 (PetCO2) responses to small muscle group exercise 
(dynamic handgrip) were determined. In the second (MRI) session, the spatial distribution of CBF 
during dynamic handgrip was assessed. 
Exercise protocol
Three bouts of 5-minute rhythmic handgrip exercise were alternated with 5 minutes of rest. 
Prior to the measurements, maximum voluntary contraction (MVC) was measured using an MRI 
compatible handgrip device (Gripforce 500N, Curdes design, Philadelphia PA, USA). The highest 
value of three measurements was set as MVC for the duration of the experiment. To achieve and 
maintain a steady state hemodynamic response to exercise, one minute of rhythmic handgripping 
at 80% MVC was followed by 60% MVC for 4 minutes. Visual feedback of the exercise rhythm (2 
seconds contraction, 2 seconds rest) and the force applied by the volunteer were displayed either 
on a laptop (TCD session) or onto a screen in the MRI scanner.
TCD session 
Subjects were in the supine position with the head supported by a pillow. Changes in CBFv were 
monitored in the proximal segment of the MCA by means of transcranial Doppler ultrasonography 
(DWL Multidop X4, Sipplingen, Germany) using a pulsed 2 MHz TCD probe at a depth of 45–55 mm 
[9]. The MCA contralateral to the handgripping hand was insonated through the temporal-window 
above the zygomatic arch at a depth of 40–60 mm. After signal optimization [24], the probe was 
immobilized by a head-band. Continuous BP and heart rate (HR) was measured non-invasively 
by finger plethysmography with an inflatable cuff placed around the middle finger of the non-
dominant hand (Nexfin, Edwards Lifesciences BMEYE, the Netherlands). End-tidal CO2 (PetCO2) 
was continuously monitored by a nasal cannula connected to a capnograph (Datex Normocap 
200, Helsinki, Finland).
MRI session
Changes in CBF were measured with a 3 Tesla Philips Achieva TX MR system (Philips, Best, The 
Netherlands), using a commercial 32-channel head coil. Subjects were instructed not to move 
their head and additional foam padding next to the head minimized motion. 
A detailed listing of scanning parameters is given in Table 7.1. The MRI protocol included a whole-
brain T1-weighted anatomical scan for anatomical depiction and gray matter segmentation, FLAIR 
of the brain and 3D Phase-Contrast angiography of the brain-feeding arteries. An experienced 
neuroradiologist (MvW) evaluated these images for structural abnormalities and the presence of 
carotid stenosis.
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CBF was assessed continuously during the exercise protocol using pseudo-continuous arterial 
spin labeling (pCASL) [32] with similar settings as in Ghariq et al. [33]. The ASL imaging volume 
was positioned to cover the cerebrum, and the labeling plane was planned perpendicular to the 
internal carotid arteries at the level of the basilar artery. Two background suppression pulses 
were applied after labeling to improve signal to noise ratio [34,33]. Finally, a separate M0 scan was 
acquired to enable quantification of CBF (TRM0 = 2000ms). 
Heart rate was derived from the finger pulse oximetry plethysmogram, either by the build-in 
scanner unit, or by a patient monitoring device (Magnitude, In-Vivo, Philadelphia, California). 
PetCO2 was sampled with a nasal cannula connected to a capnograph located outside the scanner 
(Capnomac Ultima, Datex, Helsinki, Finland), or the patient monitoring device. In a subset of 
subjects, blood pressure was monitored during resting conditions using the patient monitoring 
device. All signals were synchronized to the acquisition of the ASL scan.
MRI post-processing
The ASL images were preprocessed to obtain CBF values according to the procedures laid out 
in the consensus paper [32]. All preprocessing steps were done within the Matlab 2016a coding 
environment (Mathworks, Natick, Massachusetts, U.S.A) using SPM12 (http://www.fil.ion.ucl.ac.uk/
spm/), ASLtbx [35], and AAL [36] toolboxes. The anatomical T1-weighted scan was segmented into 
CSF, white- and gray matter probability maps. Motion correction of the ASL series was performed 
using ASLtbx, taking into account the signal intensity gradient introduced by background 
suppression [33]. The motion corrected ASL image volumes were pairwise subtracted (control – 







2 • α • T1,blood • (1–e          )
lbldur
T1,blood M0
where SI represents the spatially varying ASL signal intensity during control and label conditions. 
Reported values in literature for T1,blood (1665 ms) and labeling efficiency (α = 0.85) were assumed. 
The PLD was corrected for the time-difference of the readout of the slices, starting at 1800 ms 
for the first slice increasing by 48 ms for subsequent slices. The M0-image was calculated from 
the M0 scan by smoothing with a 5 mm FWHM 3D kernel, thresholded to limit the scan to brain 
tissue, and was corrected for finite TR with (1-exp(-TRM0/T1,gm))
-1, with T1,gm assumed to be 1260 ms. 
The temporal mean of the CBF-series was co-registered to the gray matter probability map (SPM, 
Intensity Normalization metric). 
MRI regions of interest
Regions of interest (ROIs) were defined to calculate the rCBF at multiple locations in the brain. For 
each subject, the single-subject AAL atlas [36] (Figure 7.1) was non-linearly deformed (warped) to 
the T1-weighted anatomical scan using the inverse transform obtained during the segmentation 
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Figure 7.1 | Illustration of the 
grey matter mask of a repre-
sentative subject. Regions of 
interest are indicated with color, 
showing MCA (red), precentral 
cortex (blue) and supplemen-
tary motor area (yellow).
519307-L-bw-verbree
70 | Chapter 7
step. The resulting subject-specific atlas was visually checked by overlaying the ROIs on the 
anatomical scan. All ROIs were masked by the gray matter probability map (threshold >0.9). 
Relative volumes of the ROI were calculated individually (in native space) by counting the number 
of voxels and converting to mL. ROIs were subsequently transferred to the CBF-maps, which 
were co-registered to the T1-weighted anatomical scan during the MRI post-processing steps 
(see above). Lower regions in the brain, e.g. vermis, brainstem and cerebellum were excluded 
from analysis due to a limited field-of-view of the ASL imaging module in the feet-head direction. 
The remaining ROIs of the AAL atlas were grouped in ACA, MCA and PCA flow territories [37]. 
The extent and overlap of flow territories can differ substantially between individuals, therefore 
next to the nominal MCA flow territory, a conservative and a liberal estimate of the MCA-territory 
were defined based on a surgical-anatomical atlas [37]. Specific regional CBF changes were 
investigated in the precentral and supplementary motor area (SMA) ROI as these regionals are 
generally associated with motor function. The MRI data of left handed subjects (n = 4) were 
mirrored before further analysis. To quantify the effect of visual feedback, a visual cortex ROI was 
defined by combining the calcarine and superior-, middle- and inferior occipital cortex. 
Statistics and data analysis
Data from the TCD and MRI sessions were visually inspected and images with artifacts were 
excluded from analysis. The signals of BP, the envelope curve of the transcranial Doppler spectrum 
from the MCA and PETCO2 were A/D converted at 200 Hz and stored. Mean arterial pressure 
(MAP), HR and the mean CBFv were calculated per heart-beat. Data were averaged over the three 
runs and the averaged values over the last 3 minutes of each episode of both rest or handgrip 
were used as steady-state values. Statistical analysis was performed using the Statistics toolbox 
of Matlab (v2016a). Differences within and between sessions (TCD and MRI) were inferred using 
paired t-test and ANOVA after confirming a normal distribution of the data using the Lilliefors 
test). The relation between the change in CBFv and CBF in predefined ROI’s was investigated 
by regression analysis. Levene’s test was used to assess the assumption of equal variances and 
normality of the residuals was inspected.
RESULTS
Subjects
Seven subjects were excluded based on the results of medical screening, and one subject 
declined participation after the screening process. Technical issues resulted in incomplete data in 
10 subjects, and one additional subject had a structural abnormality on the MRI scans. The final 
analysis was performed on the data of the remaining 38 subjects (13 female) with a median age 
of 55 years (range: 19–79).
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Resting values and responses to handgrip for both sessions are summarized in Table 7.2. Resting 
HR, PetCO2 and MAP were similar for the TCD and MRI sessions. During handgrip, HR increased 
similarly in TCD (10±5%, p<0.01) and MRI (9±7%, p<0.01) sessions (between sessions p = 0.23). 
No change in PetCO2 was detected in either session (p = 0.10 and p = 0.08 for TCD and MRI 
respectively). MAP increased in the TCD session by 10±5% (p<0.01) during handgrip (MAP 
response was not assessed during the MRI session).






HR (bpm) 59±7 10±5%** 60±8† 9±7%**
PetCO2 (mmHg) 39.9±3.5 1.5±4.8% 40.3±4.5
† -0.9±3.6%§
MAP (mmHg) 9 ±9 10±5%** 94±11† –
CBFv / CBFmca (cm/s / ml/100g/min) 60±14 11±12%** 46±10 -1±10%
HR: heart rate; MAP: mean arterial pressure; CBFv: cerebral blood flow velocity measured by TCD; CBFmca: CBF in the MCA 
flow territory measured by MRI. *) p<0.05, **) p<0.01 vs. Rest; †) p = n.s. vs. TCD Rest; §) p<0.05, §§) p<0.01 vs. %Delta TCD; 
Values are means±SD.
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Figure 7.2 | Comparison of CBFv and CBF averaged over the MCA ROI (CBFmca). a) Absolute values 
during rest with regression line CBFmca = 17.8 + 0.46·CBFv (p<0.001) (solid line) and 95% confidence 
interval (dotted line); b) relative response to handgrip.
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Flow territory CBF versus CBFv
Both CBFv and ftCBF in the MCA flow territory ROI responses were measured in the hemisphere 
contralateral to the exercising hand (see Figure 7.2). During rhythmic handgrip, CBFv increased 
(11 ± 12%, p<0.01), while no change was found in ftCBF (-1±10%, p = 0.15). The absence of CBF 
change in the normal MCA flow territory definition was confirmed for both the conservative 
(-0.0±10%) as well as for the liberal definition (+0.1±10%) of the ROI. During rest CBFv was linearly 
related to ftCBF (p<0.001), with a non-zero offset (p<0.01), see Figure 7.2a. 
Regional CBF versus CBFv
In Figure 7.3 the relative change rCBF in the precentral ROI is depicted against the change in 
CBFv. During handgrip exercise rCBF increased in the contralateral (8±10%; p<0.01), but not in 
the ipsilateral precentral ROI (6±18%; p = 0.12). The increase in CBFv was not correlated to the 
regional CBF increase in the precentral ROI (r = 0.16, p = 0.35).
Handgrip (%)



















Figure 7.3 | Relative changes in CBFv and regional CBF (Precentral ROI) upon handgrip.
CBF in the contralateral SMA ROI increased (8±13%; p<0.01), but did not change in the ipsilateral 
ROI ( ±13%, p = 0.13). rCBF in the visual cortex ROI increased by 9±11% (p<0.01).
ROI Volume Estimates
Volume estimates of the MCA-, Precentral- and SMA ROIs are given in Table 7.3. The relative total 
volume of the precentral ROI was 10±1% of the total MCA ROI, whereas the precentral gray matter 
volume was 7±1% relative to the MCA gray matter volume. 
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Table 7.3 | Volume estimates of regions of interest.




MCA flow territory 156±14 74±12
Precentral 15±1 5±1 9.5±0.4% 7.0±0.7%
SMA 11±1 4±1 6.8±0.3% 5.7±0.4%
ROIs are contralateral to the side handgripping. GM: gray matter; SMA: supplementary motor area. Values are mean±SD.
DISCUSSION
This study addressed whether the increase in middle cerebral artery (MCA) blood flow velocity 
as measured by TCD during small muscle group exercise parallels CBF within the relevant area of 
the brain as measured by ASL-MRI. The main finding is that the CBFv increased by 11%, whereas 
no change could be detected in the corresponding flow territory CBF, although an 8% increase in 
rCBF was detected in the functional relevant brain regions. This finding calls into question the use 
of TCD velocity changes as a proxy for cerebral blood flow changes.
To illustrate this disparity, the locations of the CBFv and CBF measurements are graphically depicted 
in Figure 7.4. The observed increase in CBFv is well within the range (8–19%) previously reported 
by studies using rhythmic handgrip [23-31]. Traditionally, an increase in in CBFv is assumed to 
imply a ftCBF response. For example, a hypothetical rCBF increase of 110% in a tenth of the flow 
territory volume (see Table 7.3) is required to increase ftCBF by 11%, which is much larger than 
observed in this study or reported in MRI literature. Conversely, the observed 8% increase in rCBF 
would predict a 0.8% increase in ftCBF, which is clearly at odds with the observed increase in CBFv. 
Although in-between scenario’s can be constructed, these black-and-white scenarios illustrate 
clearly the order of magnitude discrepancy between the measured CBFv and ftCBF.
Validity of ASL and TCD measurements
Assumptions of both TCD and ASL could attribute to the observed discrepancy. Particularly 
relevant are the assumptions that affect the percentage change as used the in the present study. 
Factors affecting only the quantitative scaling have been discussed elsewhere for TCD [38] and 
ASL-MRI [32].
In ASL-MRI, the labeling efficiency is dependent on the blood flow velocity of the arteries at 
the level of the labeling plane. Simulations showed that the efficiency decreases only by ~1% 
when velocity is increased by 20% [39,40], therefore it can be assumed that reduced labeling 
efficiency contributes little to the observed discrepancy. During exercise, faster blood flow 
shortens the transport time of the labeled blood to the tissue. Theoretically this could lead to an 
overestimation of the CBF-increase (more labeled blood arrives in the ROI), but could also lead 
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to an underestimation of the CBF response due to faster decay of the label in the tissue (label 
stays a shorter time in blood, whereas the T1 of tissue is smaller than T1 of blood). Finally, during 
exercise the T2
* of the label might be prolonged due to the higher levels of blood oxygenation 
(BOLD-effect), leading again to an overestimation of the CBF-increase [41]. Therefore, it is difficult 
to provide a clear explanation why ASL-MRI would severely underestimate the mean CBF increase 
over the MCA-flow territory. 
+8 Precentral ROI 
MCA ow territory











Impl ies when 
assuming a local 
response
Figure 7.4 | Schematic representation of the location of the regional CBF and CBFv changes observed 
in the present study. Note that the CBF also increased outside the indicated areas: in particular, the 
supplementary motor area and visual cortex which are both not supplied by the MCA. Illustrations 
adapted from Wikimedia under the creative commons license.
An important assumption in TCD is the constancy of the MCA diameter. A decrease in MCA cross-
sectional area would inverse-proportionally affect the flow, at constant velocity. In a previous 
study, we assessed the MCA cross-sectional area response during rhythmic handgrip exercise 
using high resolution MRI [42]. In that study, the exact same handgrip protocol was used as in 
the present study, although in a different study population (age range 20–59 years). On average 
a 2% decrease in cross-sectional area was observed. This difference is small and could maximally 
explain a fifth of the 11% CBFv increase observed in the present study. Therefore, the minimal 
change in MCA diameter during handgrip exercise is not the sole contributor to the discrepancy.
In transcranial Doppler ultrasonography, the reported change in CBFv is usually based on 
the average maximum velocity derived from TCD spectrum of multiple heart beats [9,38]. The 
maximum velocity is used as a proxy for the cross-sectional average velocity, which physically 
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defines flow. The relation between the maximum and cross-sectional velocity can be complex in 
the short and curved MCA (M1 segment), but is assumed stable when comparing beat-to-beat 
averages. Changes in the flow profile can offset this relation and maximum velocity potentially 
underestimates the changes in average cross-sectional velocity. However, CBFv matches the flow 
increase in the internal carotid artery during loaded cycling [43], rendering an important offset 
between maximum- and cross-sectional velocity unlikely. 
In summary, both ASL and TCD both involve assumptions that could potentially under- or 
overestimate the change in cerebral perfusion upon exercise, but reasonable estimation of the 
order of magnitude of such errors limit these to a few percentage points. Hence these do not 
satisfactory explain the order of magnitude difference between the observed CBFv and CBF 
changes. Therefore, without clear evidence of the invalidity of either of the two modalities, other 
explanations need to be considered.
Possible explanation
Shunting of arterial blood directly to the venous side through arteriovenous anastomosis, or to 
other tissues than the brain is a straightforward explanation for the discrepancy between TCD and 
MRI flow. For example, shunting would increase MCA flow while bypassing brain-tissue, hence 
leaving ftCBF unchanged. However, multiple arguments make this concept unlikely. For instance, 
it is currently accepted that the MCA is an end-artery, hence it contains no shunts and feeds 
exclusively brain-tissue. However, quantitative data on variability and functional consequences 
of shunts (leptomeningeal anastomoses) in humans are virtually lacking [44]. Moreover, the 
presence of pre-capillary arteriovenous-shunts in the brain has not been evidenced [45]. In ASL, 
shunting would be expected to show residual signal in venous compartments, as was observed 
in patients with an arterio-venous malformation [46], but not seen in healthy volunteers nor in 
our participants. Moreover, such assumed shunts would have to be “recruited” during exercise to 
accommodate an 11% increase in CBFv. Therefore, the shunting of blood flow seems an unlikely 
explanation and further research would be required to determine how bulk flow and tissue 
perfusion are related during the degree of neural recruitment involved at this type of exercise. 
Correlation CBFv with rCBF
Although the interpretation of CBFv as a proxy of CBF changes in the flow territory might be 
difficult based on our results, TCD measurements during exercise might be considered of practical 
use if changes in CBFv would be directly associated with the increase in rCBF. However, no 
correlation between the change in CBFv and change in CBF in the precentral ROI was observed 
(see Figure 7.3). The present study is considered limited to assess a possible correlation between 
rCBF and CBFv as it employed only one intensity of exercise, and the absence of correlation 
should be verified with graded exercise intensities or by employing exercise with different levels 
of complexity. Even if such an association would be confirmed, the current observations would 
still introduce several conceptual difficulties. 
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Limitations of the present study
Some limitations pertaining to the present study must be considered. The exercise protocol in the 
present study was part of a larger research program, which might have influenced the present 
results. Prior to the handgrip exercise all subjects participated in a lower body negative pressure 
LBNP experiment at -50 mmHg. The LBNP exposure was performed in both the TCD and MRI 
session and was well tolerated by all subjects. Furthermore, minimally 15 minutes of supine rest 
was allowed before the start of the handgrip protocol and therefore the effect on the response 
to exercise was assumed to be negligible. The MRI table was modified to accommodate the LBNP 
box necessitating to raise subjects and head coil by 75 mm, therefore creating an offset with the 
magnet iso-center. This did not lead to visible decrease in image quality or artifacts; furthermore, 
any possible effect would impact both the CBF measurement in rest as well as the exercise-
measurement, making it unlikely that the relative increase would be severely underestimated. The 
experiments were divided between two sessions in fixed order. Our pilot studies (unpublished 
data) and previous research [47,48] showed that the cardiovascular response upon exercise is 
highly similar when performed one week later. In the present study, comparable HR response was 
observed between sessions in addition to similar baseline parameters for HR, MAP and PetCO2. 
This suggests a comparable cardiovascular response during both sessions and we therefore 
assume a similar cerebral hemodynamic response. 
A-priori defined regions of interest (ROIs) were used to calculate the regional CBF increases. 
However, due to the heterogeneity of the CBF-response and the uncertainty in the exact location 
of the CBF response, this ROI might be sub-optimally defined. This could either result in an 
overestimation or an underestimation of the CBF response. An alternative approach would be 
the use of voxel-based statistics to define and search for clusters of significant increased CBF 
upon exercise. This would, however, make the ROI definition dependent on the CBF response 
itself and the employed threshold and it could result in large differences in ROI-volume between 
subjects. Therefore, the present study used an atlas to consistently define and evaluate regional 
CBF increase in predefined ROIs, therefore preventing a potential bias. 
Visual feedback was used during the handgrip session, which could be considered a limitation 
of the present study. Visual stimulation is a potent stimulus and we observed a corresponding 
increase of 8.7% in the visual cortex ROI. The visual cortex is normally supplied by the PCA [37] 
and this was not investigated using TCD in the present study. The same software was used for 
visual feedback during both sessions, therefore a possible influence of visual stimulation on the 
response in the MCA territory was considered unlikely and it is assumed not to have impacted the 
results of this study.
519307-L-bw-verbree






During handgrip exercise ASL determined CBF does not support the claim that TCD determined 
changes in CBFv are a proxy for CBF changes in the relevant brain areas. The results suggest an 
order of magnitude difference in the measured hemodynamic response upon exercise between 
the two modalities. Shunting of MCA blood flow during exercise bypassing the brain tissue could 
be an explanation for this discrepancy. However, evidence for such a mechanism is currently 
lacking. Implications could be far reaching for either or both modalities, indicating the need to 
further explore the relation of arterial blood flow and tissue perfusion.
Acknowledgement
The authors would like to acknowledge drs. W.J. Stok for assistance in preparing and executing 
the experiments.
519307-L-bw-verbree
78 | Chapter 7
REFERENCE LIST
1. Fox PT, Raichle ME (1986) Focal physiological uncoupling of cerebral blood flow and oxidative metabolism 
during somatosensory stimulation in human subjects. Proceedings of the National Academy of Sciences of 
the United States of America 83 (4):1140-1144
2. Ide K, Horn A, Secher NH (1999) Cerebral metabolic response to submaximal exercise. J Appl Physiol 87 
(5):1604-1608
3. Quistorff B, Secher NH, Van Lieshout JJ (2008) Lactate fuels the human brain during exercise. FASEB J 22 
(10):3443-3449. doi:10.1096/fj.08-106104
4. Raichle ME, Grubb RL, Jr., Gado MH, Eichling JO, Ter Pogossian MM (1976) Correlation between regional 
cerebral blood flow and oxidative metabolism. In vivo studies in man. ArchNeurol 33 (8):523-526
5. Laughlin MH, Davis MJ, Secher NH, van Lieshout JJ, Arce-Esquivel AA, Simmons GH, Bender SB, Padilla J, 
Bache RJ, Merkus D, Duncker DJ (2012) Peripheral circulation. Compr Physiol 2 (1):321-447. doi:10.1002/cphy.
c100048
6. Lassen NA, Ingvar DH, Skinhoj E (1978) Brain function and blood flow. Sci Am 239 (4):62-71
7. Olesen J (1971) Contralateral focal increase of cerebral blood flow in man during arm work. Brain 94 (4):635-
646
8. Obrist WD, Thompson HK, Jr., Wang HS, Wilkinson WE (1975) Regional cerebral blood flow estimated by 
133-xenon inhalation. Stroke 6 (3):245-256
9. Aaslid R, Markwalder TM, Nornes H (1982) Noninvasive transcranial Doppler ultrasound recording of flow 
velocity in basal cerebral arteries. J Neurosurg 57 (6):769-774
10. Jorgensen LG, Perko M, Hanel B, Schroeder TV, Secher NH (1992) Middle cerebral artery flow velocity and 
blood flow during exercise and muscle ischemia in humans. J Appl Physiol 72 (3):1123-1132
11. Jorgensen LG, Perko G, Secher NH (1992) Regional cerebral artery mean flow velocity and blood flow during 
dynamic exercise in humans. J Appl Physiol 73 (5):1825-1830
12. Kim YS, Seifert T, Brassard P, Rasmussen P, Vaag A, Nielsen HB, Secher NH, van Lieshout JJ (2015) Impaired 
cerebral blood flow and oxygenation during exercise in type 2 diabetic patients. Physiological reports 3 (6):1-
13. doi:10.14814/phy2.12430
13. Hellstrom G, Fischer-Colbrie W, Wahlgren NG, Jogestrand T (1996) Carotid artery blood flow and middle 
cerebral artery blood flow velocity during physical exercise. J Appl Physiol 81 (1):413-418
14. Sato K, Ogoh S, Hirasawa A, Oue A, Sadamoto T (2011) The distribution of blood flow in the carotid and 
vertebral arteries during dynamic exercise in humans. J Physiol 589 (Pt 11):2847-2856. doi:10.1113/
jphysiol.2010.204461
15. Sato K, Moriyama M, Sadamoto T (2009) Influence of central command on cerebral blood flow at the onset of 
exercise in women. Exp Physiol 94 (11):1139-1146
16. Friedman DB, Friberg L, Mitchell JH, Secher NH (1991) Effect of axillary blockade on regional cerebral blood 
flow during static handgrip. J Appl Physiol 71 (2):651-656
17. Williamson JW, McColl R, Mathews D (2003) Evidence for central command activation of the human insular 
cortex during exercise. J Appl Physiol 94 (5):1726-1734
18. Williamson JW, Friedman DB, Mitchell JH, Secher NH, Friberg L (1996) Mechanisms regulating regional 
cerebral activation during dynamic handgrip in humans. J Appl Physiol 81 (5):1884-1890
19. Williamson JW, McColl R, Mathews D, Ginsburg M, Mitchell JH (1999) Activation of the insular cortex is affected 
by the intensity of exercise. J Appl Physiol 87 (3):1213-1219
20. Fontes EB, Okano AH, De Guio F, Schabort EJ, Min LL, Basset FA, Stein DJ, Noakes TD (2015) Brain activity 
and perceived exertion during cycling exercise: an fMRI study. Br J Sports Med 49 (8):556-560. doi:10.1136/
bjsports-2012-091924
21. Mehta JP, Verber MD, Wieser JA, Schmit BD, Schindler-Ivens SM (2009) A novel technique for examining 
human brain activity associated with pedaling using fMRI. Journal of neuroscience methods 179 (2):230-239. 
doi:10.1016/j.jneumeth.2009.01.029
519307-L-bw-verbree





22. King M, Rauch HG, Stein DJ, Brooks SJ (2014) The handyman’s brain: a neuroimaging meta-analysis describing 
the similarities and differences between grip type and pattern in humans. NeuroImage 102 Pt 2:923-937. 
doi:10.1016/j.neuroimage.2014.05.064
23. Jørgensen LG, Perko G, Payne G, Secher NH (1993) Effect of limb anesthesia on middle cerebral response to 
handgrip. American journal of physiology Heart and circulatory physiology 264 (2 Pt 2):H553-H559
24. Pott F, Jensen K, Hansen H, Christensen NJ, Lassen NA, Secher NH (1996) Middle cerebral artery blood 
velocity and plasma catecholamines during exercise. Acta Physiol Scand 158 (4):349-356. doi:10.1046/j.1365-
201X.1996.564325000.x
25. Pott F, Ray CA, Olesen HL, Ide K, Secher NH (1997) Middle cerebral artery blood velocity, arterial diameter and 
muscle sympathetic nerve activity during post-exercise muscle ischaemia. Acta Physiol Scand 160 (1):43-47
26. Ide K, Pott F, Van Lieshout JJ, Secher NH (1998) Middle cerebral artery blood velocity depends on cardiac 
output during exercise with a large muscle mass. Acta Physiol Scand 162 (1):13-20. doi:10.1046/j.1365-
201X.1998.0280f.x
27. Giller CA, Giller AM, Cooper CR, Hatab MR (2000) Evaluation of the cerebral hemodynamic response to 
rhythmic handgrip. J Appl Physiol 88:2205-2213
28. Rasmussen P, Plomgaard P, Krogh-Madsen R, Kim YS, van Lieshout JJ, Secher NH, Quistorff B (2006) MCA 
Vmean and the arterial lactate-to-pyruvate ratio correlate during rhythmic handgrip. J Appl Physiol 101 
(5):1406-1411. doi:10.1152/japplphysiol.00423.2006
29. Kim YS, Krogh-Madsen R, Rasmussen P, Plomgaard P, Ogoh S, Secher NH, van Lieshout JJ (2007) Effects of 
hyperglycemia on the cerebrovascular response to rhythmic handgrip exercise. Am J Physiol Heart Circ 
Physiol 293 (1):H467-473. doi:10.1152/ajpheart.00045.2007
30. Ono T, Hasegawa Y, Hori K, Nokubi T, Hamasaki T (2007) Task-induced activation and hemispheric dominance 
in cerebral circulation during gum chewing. J Neurol 254 (10):1427-1432. doi:10.1007/s00415-007-0570-3
31. Miyazawa T, Horiuchi M, Ichikawa D, Sato K, Tanaka N, Bailey DM, Ogoh S (2011) Kinetics of exercise-induced 
neural activation; interpretive dilemma of altered cerebral perfusion. Exp Physiol
32. Alsop DC, Detre JA, Golay X, Gunther M, Hendrikse J, Hernandez-Garcia L, Lu H, MacIntosh BJ, Parkes LM, 
Smits M, van Osch MJ, Wang DJ, Wong EC, Zaharchuk G (2015) Recommended implementation of arterial 
spin-labeled perfusion MRI for clinical applications: A consensus of the ISMRM perfusion study group and the 
European consortium for ASL in dementia. Magnetic resonance in medicine : official journal of the Society of 
Magnetic Resonance in Medicine / Society of Magnetic Resonance in Medicine 73 (1):102-116. doi:10.1002/
mrm.25197
33. Ghariq E, Chappell MA, Schmid S, Teeuwisse WM, van Osch MJ (2014) Effects of background suppression on 
the sensitivity of dual-echo arterial spin labeling MRI for BOLD and CBF signal changes. NeuroImage 103:316-
322. doi:10.1016/j.neuroimage.2014.09.051
34. Ye FQ, Frank JA, Weinberger DR, McLaughlin AC (2000) Noise reduction in 3D perfusion imaging by attenuating 
the static signal in arterial spin tagging (ASSIST). Magnetic resonance in medicine : official journal of the 
Society of Magnetic Resonance in Medicine / Society of Magnetic Resonance in Medicine 44 (1):92-100
35. Wang Z, Aguirre GK, Rao H, Wang J, Fernandez-Seara MA, Childress AR, Detre JA (2008) Empirical optimization 
of ASL data analysis using an ASL data processing toolbox: ASLtbx. Magnetic resonance imaging 26 (2):261-
269. doi:10.1016/j.mri.2007.07.003
36. Tzourio-Mazoyer N, Landeau B, Papathanassiou D, Crivello F, Etard O, Delcroix N, Mazoyer B, Joliot M (2002) 
Automated anatomical labeling of activations in SPM using a macroscopic anatomical parcellation of the MNI 
MRI single-subject brain. NeuroImage 15 (1):273-289. doi:10.1006/nimg.2001.0978
37. Tatu L, Moulin T, Bogousslavsky J, Duvernoy H (1998) Arterial territories of the human brain: cerebral 
hemispheres. Neurology 50 (6):1699-1708
38. Kontos HA (1989) Validity of cerebral arterial blood flow calculations from velocity measurements. Stroke 20 
(1):1-3
39. Gevers S, Nederveen AJ, Fijnvandraat K, van den Berg SM, van OP, Heijtel DF, Heijboer H, Nederkoorn PJ, 
Engelen M, van Osch MJ, Majoie CB (2012) Arterial spin labeling measurement of cerebral perfusion in 
children with sickle cell disease. J Magn Reson Imaging 35 (4):779-787. doi:10.1002/jmri.23505 [doi]
40. Dai W, Garcia D, de BC, Alsop DC (2008) Continuous flow-driven inversion for arterial spin labeling using 
pulsed radio frequency and gradient fields. Magnetic resonance in medicine 60 (6):1488-1497
519307-L-bw-verbree
Systemic and cerebral hemodynamics in response to cardiovascular 
challenges – the heart-brain connection  Systemic and cerebral 
hemodynamics in response to cardiovascular challenges – the heart-
brain connection  Systemic and cerebral hemodynamics in response 
to cardiovascular challenges – the heart-brain connection  Systemic 
and cerebral hemodynamics in response to cardiovascular challenges 
– the heart-brain connection  Systemic and cerebral hemodynamics 
in response to cardiovascular challenges – the heart-brain connection 
Systemic and cerebral hemodynamics in response to cardiovascular 
challenges – the heart-brain connection  Systemic and cerebral 
hemodynamics in response to cardiovascular challenges – the heart-
brain connection  Systemic and cerebral hemodynamics in response 
to cardiovascular challenges – the heart-brain connection  Systemic 
and cerebral hemodynamics in response to cardiovascular challenges 
– the heart-brain connection  Systemic and cerebral hemodynamics 
in response to cardiovascular challenges – the heart-brain connection 
Systemic and cerebral hemodynamics in response to cardiovascular 
challenges – the heart-brain connection  Systemic and cerebral 
hemodynamics in response to cardiovascular challenges – the heart-
brain connection  Systemic and cerebral hemodynamics in response 
to cardiovascular challenges – the heart-brain connection  Systemic 
and cerebral hemodynamics in response to cardiovascular challenges 
– the heart-brain connection  Systemic and cerebral hemodynamics 
in response to cardiovascular challenges – the heart-brain connection 
Systemic and cerebral hemodynamics in response to cardiovascular 
challenges – the heart-brain connection  Systemic and cerebral 
hemodynamics in response to cardiovascular challenges – the heart-
brain connection  Systemic and cerebral hemodynamics in response 
to cardiovascular challenges – the heart-brain connection  Systemic 
and cerebral hemodynamics in response to cardiovascular challenges 
– the heart-brain connection  Systemic and cerebral hemodynamics 
in response to cardiovascular challenges – the heart-brain connection 
Systemic and cerebral hemodynamics in response to cardiovascular 
challenges – the heart-brain connection  Systemic and cerebral 
hemodynamics in response to cardiovascular challenges – the heart-
brain connection  Systemic and cerebral hemodynamics in response 
80 | Chapter 7
41. Petersen ET, Zimine I, Ho YC, Golay X (2006) Non-invasive measurement of perfusion: a critical review of 
arterial spin labelling techniques. Br J Radiol 79 (944):688-701. doi:10.1259/bjr/67705974
42. Verbree J, Bronzwaer A, van Buchem MA, Daemen M, van Lieshout JJ, van Osch M (2016) Middle cerebral 
artery diameter changes during rhythmic handgrip exercise in humans. J Cereb Blood Flow Metab. 
doi:10.1177/0271678X16679419
43. Hellstrõm G, Fischer-Colbrie W, Wahlgren NG, Jøgestrand T (1996) Carotid artery blood flow and middle 
cerebral artery blood flow velocity during physical exercise. J Appl Physiol 81 (1):413-418
44. Brozici M, van der Zwan A, Hillen B (2003) Anatomy and functionality of leptomeningeal anastomoses: a 
review. Stroke 34 (11):2750-2762. doi:10.1161/01.str.0000095791.85737.65
45. Duvernoy HM, Delon S, Vannson JL (1981) Cortical blood vessels of the human brain. Brain Res Bull 7 (5):519-
579
46. Le TT, Fischbein NJ, Andre JB, Wijman C, Rosenberg J, Zaharchuk G (2012) Identification of venous signal 
on arterial spin labeling improves diagnosis of dural arteriovenous fistulas and small arteriovenous 
malformations. Am J Neuroradiol 33 (1):61-68. doi:10.3174/ajnr.A2761
47. Sinoway L, Shenberger J, Leaman G, Zelis R, Gray K, Baily R, Leuenberger U (1996) Forearm training attenuates 
sympathetic responses to prolonged rhythmic forearm exercise. J Appl Physiol 81 (4):1778-1784
48. Lopez MG, Silva BM, Joyner MJ, Casey DP (2012) Ischemic exercise hyperemia in the human forearm: 
reproducibility and roles of adenosine and nitric oxide. Eur J Appl Physiol 112 (6):2065-2072. doi:10.1007/
s00421-011-2035-8
519307-L-bw-verbree
Systemic and cerebral hemodynamics in response to cardiovascular 
challenges – the heart-brain connection  Systemic and cerebral 
hemodynamics in response to cardiovascular challenges – the heart-
brain connection  Systemic and cerebral hemodynamics in response 
to cardiovascular challenges – the heart-brain connection  Systemic 
and cerebral hemodynamics in response to cardiovascular challenges 
– the heart-brain connection  Systemic and cerebral hemodynamics 
in response to cardiovascular challenges – the heart-brain connection 
Systemic and cerebral hemodynamics in response to cardiovascular 
challenges – the heart-brain connection  Systemic and cerebral 
hemodynamics in response to cardiovascular challenges – the heart-
brain connection  Systemic and cerebral hemodynamics in response 
to cardiovascular challenges – the heart-brain connection  Systemic 
and cerebral hemodynamics in response to cardiovascular challenges 
– the heart-brain connection  Systemic and cerebral hemodynamics 
in response to cardiovascular challenges – the heart-brain connection 
Systemic and cerebral hemodynamics in response to cardiovascular 
challenges – the heart-brain connection  Systemic and cerebral 
hemodynamics in response to cardiovascular challenges – the heart-
brain connection  Systemic and cerebral hemodynamics in response 
to cardiovascular challenges – the heart-brain connection  Systemic 
and cerebral hemodynamics in response to cardiovascular challenges 
– the heart-brain connection  Systemic and cerebral hemodynamics 
in response to cardiovascular challenges – the heart-brain connection 
Systemic and cerebral hemodynamics in response to cardiovascular 
challenges – the heart-brain connection  Systemic and cerebral 
hemodynamics in response to cardiovascular challenges – the heart-
brain connection  Systemic and cerebral hemodynamics in response 
to cardiovascular challenges – the heart-brain connection  Systemic 
and cerebral hemodynamics in response to cardiovascular challenges 
– the heart-brain connection  Systemic and cerebral hemodynamics 
in response to cardiovascular challenges – the heart-brain connection 
Systemic and cerebral hemodynamics in response to cardiovascular 
challenges – the heart-brain connection  Systemic and cerebral 
hemodynamics in response to cardiovascular challenges – the heart-
brain connection  Systemic and cerebral hemodynamics in response 
CHAPTER 8
Influ nce of the cardiac cycle on pCASL: 
cardiac triggering of the end-of-labeling
J. Verbree
M.J.P. van Osch
Magn Reson Mater Phy (MAGMA) 2017 Mar 9
DOI: 10.1007/s10334-017-0611-6
519307-L-bw-verbree
82 | Chapter 8
ABSTRACT
Object: In arterial spin labeling (ASL), the cardiac cycle might adversely influence signal-stability 
by varying the amount of label created, labeling efficiency and/or transport times. Due to the 
long labeling duration in pseudo-Continuous ASL (pCASL), the blood labeled last contributes 
most to the ASL-signal. The present study investigated, using numerical simulations and in-vivo 
experiments, the effect of the cardiac cycle on pCASL, thereby focusing on the end-of-labeling.
Materials and Methods: In the in-vivo experiments the end-of-labeling was timed to a specific 
cardiac phase while a long labeling duration of >7 seconds was used to isolate the influence of 
the lastly labeled spins on ASL-signal stability. 
Results: Simulations showed dependence of the ASL-signal on the cardiac phase of the end-of-
labeling, and that the variation in signal was more pronounced at lower heart rates. The ASL-
signal variation was small (~4%), but could be effectively reduced by simulated end-of-labeling 
triggering. In-vivo, no difference in mean CBF (p = 0.58) nor in CBF temporal-STD (p = 0.44) could 
be detected between triggered and non-triggered acquisitions.
Conclusion: Influence of the cardiac cycle on pCASL-signal stability is small and triggering the 
start-of-labeling and end-of-labeling can be considered not to have practical implications to 
improve stability.
Keywords
Perfusion magnetic resonance imaging; Cerebrovascular circulation; Pulsatile Flow; Cerebral 
blood flow
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Pseudo Continuous Arterial Spin Labeling (pCASL) is the current recommended and validated 
non-invasive MR technique to image cerebral blood flow (CBF) [1,2]. The pCASL sequence consists 
of separate label and control acquisitions which are subtracted to yield a CBF measurement. 
Since labeling efficiency of pCASL depends on the blood flow velocity [3] and the recommended 
labeling duration is approximately two times the cardiac interval, perturbations of the ASL-signal 
due to variation in timing of the acquisitions with respect to the cardiac cycle should be expected. 
Such physiological noise could potentially be reduced by synchronizing the ASL acquisitions to 
the cardiac cycle. Synchronizing the moment of labeling to the cardiac cycle by means of cardiac 
triggering has been shown to reduce signal variability over time in pulsed ASL [4,5]. However, 
pulsed ASL has a much shorter labeling duration (≈20 ms) compared to pCASL (1500–2000 ms) 
and the generation of label is therefore almost instantaneous and can easily be timed to always 
happen at the same moment within the cardiac cycle. A similar cardiac triggering approach has 
previously been investigated in continuous ASL by triggering the start of the labeling. However, no 
improvements in signal stability were observed using this approach [6]. This might be explained 
by the long labeling duration that will result in asynchronous timing at the end of the labeling 
and the moment of imaging even when the start of the labeling was triggered. 
In ASL, the magnetic labeling of blood decays with the T1 of arterial blood (at least until the label 
is exchanged with brain tissue after which it will decay with the T1 of tissue). Label generated later 
in the labeling period will be less affected by this decay and will therefore contribute more to the 
detected signal. For example, at a labeling duration of 1.8 seconds, label generated at the end of 
the labeling period contributes a factor three more to the totally detected ASL-signal compared 
to label generated at the start of labeling. Therefore, the largest contribution to the ASL-signal 
arises from the end of the labeling period. The greatest impact of cardiac triggering on ASL-signal 
stability should therefore be expected when triggering the end-of-labeling.
Three main effects of flow velocity in the feeding arteries on pCASL signal stability can be 
expected. First, the amount of label generated is proportional to the volume of spins flowing 
through the labeling plane and thus on the blood flow velocity. Secondly, the labeling efficiency 
is known to depend on the velocity of the flowing blood. Finally, the transport time of label to 
the brain tissue is dependent on the blood flow velocity and will influence the relative time the 
label spends in the blood versus the tissue compartment. That is, faster delivery (i.e. higher flow 
velocity) of the label to the tissue will reduce the ASL-signal due to smaller T1 in tissue compared 
to the blood compartment. Therefore, in summary, both the generation and the delivery of the 
label are dependent on the blood flow velocity which varies over the cardiac cycle. Both effects 
could have an independent, but opposite influence on the pCASL-signal stability. Furthermore, 
these effects are expected to have a stronger impact on the ASL-signal at the end-of-labeling than 
at the start of the labeling.
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The aim of the present study was to investigate the influence of the cardiac cycle on pCASL-signal 
by studying the influence of triggering the end-of-labeling on the pCASL-signal stability. By 
focusing on the end-of-labeling, the moment of the largest influence is isolated, thereby providing 
a worst-case scenario estimation of the influence of the cardiac cycle on the pCASL-signal and 
its stability. Simulations were used to assess the influence of pulsatile flow in combination with 
variations in heart rate on the pCASL-signal stability. Subsequently, in-vivo experiments with end-
of-labeling triggering were performed in normal healthy subjects to confirm the findings from 
these simulations. During the in-vivo experiments impractically long labeling durations were 
employed to isolate the effect of triggering the end-of-labeling without confounding influences 
of variation in the total labeling duration. 
MATERIALS AND METHODS
Numerical model
A numerical model was implemented in MATLAB 2016a (Mathworks, Natick, MA, USA) to 
investigate the effect of the cardiac cycle on the ASL-signal, by simulating both label generation 
and label delivery. The model was subsequently used to investigate the effect of pulsatile flow, 
heart rate variability and end-of-labeling triggering.
The numerical model simulates the label generation in a single artery and the delivery of the 
labeled spins into a large tissue compartment, which acts as sink. Fresh blood flows into the artery 
at the labeling plane according to a typical velocity curve as encountered in the internal carotid 
artery of an adult person (see Figure 8.1). The arterial compartment consists of a single 300 mm 
long artery discretized into blocks of 0.01 mm length. Blood flow is simulated by shifting blocks, 
so that for blood flowing at 24 cm/s a transport time through the arterial compartment of 1250 ms 
is achieved. Labeling of blood is simulated by introducing blocks with inverted magnetization, 
while taking into account the labeling efficiency (0.85). When no labeling is applied, the blood 
magnetization is set to the fully relaxed magnetization (M0 = 1.0). Each iteration (1 ms) the blood 
is pushed into the artery. Blood at the end of the artery is subsequently pushed into the tissue 
compartment, which has a size equal to 250.000 blocks. Subsequently, the longitudinal (T1) 
magnetization of all blocks in the arterial and tissue compartments is updated according to the 
Bloch equations [7]:
Mz(t+dt) = Mz(t) • e
-dt/T1 +M0 • (1– e
-dt/T1)
where the time-step (dt) is taken as 1 ms and the T1 is set to T1,blood (1664 ms [8]) and T1,tissue 
(1105 ms, estimate for a voxel containing both gray and white matter [9]) for the arterial- and 
tissue compartments, respectively. 
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The control condition of the ASL experiment is not explicitly simulated, but is assumed to be 
equal to the total sum of blocks making up the tissue compartment. This implies that we assume 
that the inflowing magnetization is only affected during the label condition and that the control 
condition is perfect and unaffected by the timing with respect to the cardiac cycle. The blood 
flow is calculated from the difference (ΔM) between the control condition and simulated label 
signal and subsequently quantified according to the consensus formula by correcting for the 




The flow, or CBF, is the parameter of interest of the simulation and will be referred to as “signal” or 
“ASL-signal” throughout the manuscript. The recommended timing of 1800 ms for labeling and 
PLD are used in the initial simulations. 
Pulsatile blood flow is simulated by repeating the typical velocity curve (Figure 8.1) to fill the entire 
duration of the simulation. To isolate the effect of flow pulsatility during labeling (or the PLD), 
the velocity is set, for some experiments, equal to the mean velocity (i.e. constant velocity, no 
pulsatility) during certain sub-parts of the ASL sequence. The heart rate was modified by altering 
the duration of the cardiac cycle, i.e. by linearly scaling the flow velocity curve in the temporal 
domain. Heart rate variability is achieved in the same way, by randomly altering the duration 
of each cardiac cycle. Note that the pulsatility (difference between minimum and maximum 
velocity) is not altered throughout the simulations. The timing of the arrival of label in the tissue 
compartment is characterized by the bolus arrival time (BAT) and the tail arrival time (TAT). BAT is 
defined as the first non-zero ASL-signal value arriving in the tissue compartment, whereas TAT is 
defined as the last non-zero ASL-signal value leaving the arterial compartment.
Labeling efficiency is velocity-dependent and varies between the cardiac phases. The labeling 
efficiency for a single velocity has been described in a numerical model [10]. However, the flow 
profile within the vessel varies with the distance from the vessel wall. The data from the numerical 
model [10] was recalculated assuming parabolic flow profile in the simulated artery (see Figure 
8.1b). To isolate the effects of spatially as well as temporally varying labeling efficiencies due to 
blood velocity differences from other influences on ASL signal stability, labeling efficiency was 
assumed constant for the other simulations.
The resulting ASL-signal and other variables (e.g. BAT) are expressed relative to the signal as 
obtained from simulations with a constant mean flow velocity as input. The relative signal (ΔS) 
is expressed as: ΔS = (B - A)/A · 100%, where A represents the constant- and B pulsatile flow 
condition. The cardiac phase is defined as the normalized timing within the cardiac cycle and runs 
therefore from 0 to 1. Mean and standard deviations of the cardiac phase are calculated by taking 
into account that the cardiac phase “wraps around” each cardiac cycle, i.e. circular statistics [11]. 
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Figure 8.1 | Graphical representation of a) a typical velocity curve from a representative subject of the 
present study in the internal carotid artery, which is used as template in the simulations and b) the 
velocity dependent labeling efficiency as employed in the simulations. The labeling efficiency (dashed 
line) is adapted from the numerical model described in [10], while assuming parabolic flow profile in the 
simulated artery (blue line). The dotted line denotes the average velocity (24 cm/s) for visual reference.
In-vivo experiments
Data from eight healthy volunteers (4 female) with a mean age of 30 years (range 23–52), were 
acquired on a Philips 3T MRI (Achieva, Philips, Best, The Netherlands). All participants were 
screened for MRI safety compliance and the study protocol was approved by the Ethics Review 
Board of the Leiden University Medical Center. Prior written informed consent was obtained from 
all subjects and the study was performed in accordance with the Helsinki protocol. 
The vendor supplied pCASL sequence was modified to incorporate both start-of-labeling as well 
as end-of-labeling triggering. A graphical representation of the ASL sequence in relation to the 
trigger and the employed trigger-delays is depicted in Figure 8.2. To stop the end-of-labeling in 
a certain cardiac phase, a delay parameter was set on the scanner that determines the additional 
labeling duration after receiving a cardiac trigger event. The delay parameter was set by the 
operator to three distinct cardiac phases (a, b and c) based upon the subject’s velocity curve, 
see Figure 8.1. The velocity curve was obtained prior to the ASL acquisition by means of phase 
contrast MRA (for acquisition parameters, see Table 8.1). The minimum labeling duration, i.e. the 
moment after which the scanner will look for the next cardiac trigger, was chosen so that the 
expected average labeling duration was 7500 ms.
The triggered scan was acquired continuously, cycling through the cardiac phases (a-b-c-a-b-c....) 
resulting in 20 label and control images for each cardiac phase. In addition to end-of-labeling 
triggering, both control and label acquisitions were triggered at the start-of-labeling to exclude 
any residual influence of the start-of-labeling. The control condition was defined to have the same 
labeling duration as the preceding, end-of-labeling triggered label acquisition, this to ensure 
equal effects on static tissue magnetization for the control and label condition. A non-triggered 
reference ASL scan was acquired with the same imaging parameters and a labeling duration of 
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Figure 8.2 | Schematic representation of the modified pCASL sequence (top) with respect to the 
labeling RF, finger pulse-oxymetry signal (PPU) and blood flow velocity at the labeling plane. “Labeling” 
indicates the minimum labeling duration (7500 ms – delay). Arrows indicate the cardiac trigger and 
moment of end-of-labeling. Note the shift between finger PPU trigger and velocity during labeling.
The post-processing of the in-vivo data were performed in MATLAB v2016a (Natick, MA, US) with 
the SPM12 toolbox. After motion correction, the ASL-images were quantified using the consensus 
formula, taking into account the increase in PLD for later acquired slices (36 ms inter-slice interval 
with ascending slice-order, starting from 1800ms) [1]: 
=





2 • α • T1,blood • (1–e          )
lbldur
T1,blood M0
The quantification was performed per dynamic to correct for the varying labeling duration while 
triggering the end-of-labeling. The global scaling factor M0 was obtained from the maximum “pure 
water” CSF signal (M0,csf) in the lateral ventricles of the non-triggered scan assuming a fully relaxed 
signal at a repetition time of 8.2 seconds. The M0,csf was corrected for the water content of arterial 
blood (76%) to obtain the value of fully relaxed spin in blood: M0,blood = M0,csf · 0.76 [12]. The average 
quantified CBF was subsequently calculated by employing a gray matter mask obtained from the 
segmentation of the T1-weighed scan. Differences between the (non-)triggered conditions were 
assessed using the non-parametric Friedman’s test (Matlab 2016a). 
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The ASL-signal evolution in the tissue compartment is depicted in Figure 8.3 for three constant 
flow conditions. Increased flow rate during the PLD (while flow during labeling remained constant) 
caused the tail of the labeled blood (bolus) to arrive earlier in the tissue compartment. The lower 
T1 in the tissue compartment with respect to the blood compartment increased the rate of signal 
decay. Therefore, a higher flow rate during the PLD resulted in less detected ASL-signal (see inset, 
Figure 8.3a). 
Changing the flow only during labeling had two effects (see Figure 8.3b): first, the ASL-signal 
increased with the higher flow rate as expected, i.e. more spins are labeled; secondly, the bolus 
arrival time (BAT) became shorter (horizontal axis, Figure 8.3b). The second effect also leads to 
faster decay of the ASL-signal similar to the results for increased flow velocity during the PLD 
due to the shorter T1 of tissue. Comparing the signal intensity in the insets of Figure 8.3, it can be 
appreciated that the first (i.e. flow) effect dominates over the compartmental T1-effect. Finally, 


























Time (ms)a b c
Figure 8.3 | Simulated ASL-signal evolution in the tissue compartment (top panels) during constant 
flow. Constant velocity increase/decrease during: a) PLD only; b) labeling only; and c) both labeling 
and PLD. The insets show a close-up of the signals at the moment of imaging (same scale for all insets).
Simulations: pulsatile flow
The effect of pulsatile flow on the signal inflow in the tissue compartment is depicted in Figure 
8.4. The labeling duration (1800 ms) was set exactly equal to two cardiac cycles (R-R interval 
900 ms) and the velocity of blood during the PLD was set to the average velocity over one cardiac 
cycle. Therefore, the volume of blood that is labeled was constant for each simulation and thus 
independent of the cardiac phase of the start-of-labeling. 
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The pulsatile flow can be seen to influence the ASL-signal relative to the simulation with constant 
flow (Figure 8.4a), even while the volume of label created was equal and constant. Therefore, 
differences in the exact timings when label is created (start- versus the end of the labeling) 
appear to influence the detected signal even after accounting for loss of label due to longitudinal 
relaxation. Changes in the bolus arrival time (Figure 8.4b) illustrate the variation in timing of 
label delivery and the influence of compartmental T1 differences. Setting the same T1 for both 
compartments resulted in a very similar signal profile (Figure 8.4a, yellow curve). Finally, adding 
pulsatile flow during the PLD (Figure 8.4a, red curve) resulted in a slightly stronger influence 
on the timing of delivery (i.e. of the bolus tail), which induced only small differences in signal 
fluctuations.
0 0.5 1
























 c end labelinga b
Figure 8.4 | Simulated pulsatile flow of two cardiac cycles during labeling (R-R interval 900 ms = 67 bpm). 
a) ASL-signal of pulsatile flow during label only (yellow), label only and equal T1 for blood and tissue 
compartments (blue) and pulsatile flow during labeling and PLD (red). b) Bolus arrival time (BAT). BAT 
curve was equal for all three conditions; therefore a single curve is shown. All signals are normalized to 
the constant flow condition and aligned to the cardiac phase at the end-of-labeling.
Simulations: heart rate
In normal physiological conditions the heart rate will not exactly match the labeling duration 
and consequently the volume of labeled blood will vary, depending on the cardiac phase of the 
start- and thus also the end-of-labeling. Multiple fixed heart rates between 40 and 90 bpm were 
simulated and the phase of the start-of-labeling was varied to cover the entire cardiac cycle. First, 
the effect of pulsatile flow during labeling was investigated (while flow was constant during the 
PLD). 
The volume of labeled spins (i.e. the number of spins labeled, which should not be confused with 
the detected ASL-signal at which point the label will have decayed considerably) can be seen 
to depend on the cardiac phase when labeling stopped (Figure 8.5a) (except for the case when 
labeling equals exactly 2 cardiac cycles when the labeled volume was, again, constant (Figure 
8.5a, 67 bpm yellow)). The relative signal variation over the cardiac cycle (min-max range) was 
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notably higher at lower heart rates (Figure 8.5b). Although visually there is a strong resemblance 
between the shape of labeled volume and the ASL-signal, the special case of constant labeling 
volume (Figure 8.5a, 67 bpm yellow) illustrates that there is a similar amount of signal variation 
even when there is no variation in labeled volume. Moreover, the curves in Figure 8.5b are all 
synchronized with respect to the end of-labeling, whereas after sorting them versus the start of 
labeling (Figure 8.5d) this coherence is lost. Therefore, the signal variation in Figure 8.5b shows an 
effect of the end-of-labeling rather than an effect of labeled volume or start-of-labeling.
The effect of pulsatile flow during the PLD (while keeping flow constant during labeling) on the 
relative signal showed a very similar pattern as the relative signal due to pulsatile flow during 
labeling (compare Figure 8.5a-c with Figure 8.5e-g). The effect of label generation and delivery 
will therefore reinforce each other, independent of heart rate.
Simulations: labeling efficiency
Until this moment labeling efficiency was assumed constant over the cardiac cycle, however 
it is known to be dependent on the velocity of the blood [10,13]. Velocity-dependent labeling 
efficiency (Figure 8.1) was, therefore, added to the simulations with pulsatile flow during labeling 
and PLD. Similar curves were obtained as with constant labeling efficiency: the difference 
between constant and velocity dependent labeling efficiency was only -0.35±0.08 percentage 
point (95%-confidence interval: -0.37, -0.33%), as shown graphically in Figure 8.5h. The influence 
of labeling efficiency was more pronounced at higher heart rates.
Simulations: labeling duration
At a very long labeling duration of 7 seconds, increasing the labeling duration by 1 second had 
no effect on the relative signal within the precision of the simulation (Figure 8.6a). As the cardiac 
phase of end-of-labeling shifts with increasing labeling duration, the BAT can be seen to shift 
as well (Figure 8.6b). The relative labeled volume increases with labeling duration as expected 
(Figure 8.6c).
Simulations: triggering the end-of-labeling
The bridge to the in-vivo experiments was made by simulating the end-of-labeling triggering using 
the same parameters as during the in-vivo experiments. After labeling for minimally 7 seconds, 
labeling was continued for an additional labeling period after a trigger; this was dubbed “trigger 
delay” (see In-vivo experiment Methods sections for details). The normal physiological situation 
was simulated by adding heart rate variability (HRV) to the cardiac cycle. For this simulation, a 
pulsatile flow profile with a HRV of 100 ms was generated at two mean heart rates of 40 and 90 bpm 
as two extreme cases. Due to the stochastic nature of the HRV, each trigger-delay was simulated 
33 times. The start-of-labeling was also triggered similarly as done in the in-vivo experiment. The 
non-triggered case was simulated 33 times with a mean labeling duration of 7500 ms.
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a b cΦc end labeling Φc end labeling Φc end labeling
Figure 8.6 | Simulated effect of additional labeling duration on: a) relative ASL-signal; b) Bolus arrival 
time and c) Labeled volume. Pulsatile flow was simulated during labeling and PLD at a fixed heart rate 
of 50 bpm. All values are normalized to the constant flow condition with a labeling duration of 7000ms.
From Figure 8.7a it can be appreciated that HRV introduces uncertainty in the determination of 
the exact phase of the end-of-labeling (i.e. variation in the x-axis). A similar pattern in relative ASL-
signal as in Figure 8.5b can be observed. As the variation in ASL-signal due to labeled volume is 
negligible at these long labeling durations, this is mostly the effect of the end-of-labeling phase. 
The variation in signal is, again, more pronounced at the lower heart rate both for the triggered 
(Figure 8.7a) as well as for the non-triggered (Figure 8.7b) case. The standard deviation of the 
non-triggered ASL-signal averaged over the cardiac cycle was 4.7% and 2.0%, for 40 and 90 bpm 
respectively (see Figure 8.7b). The standards deviation along the y-axis in Figure 8.7a were plotted 
separately in Figure 8.7c. A strong reduction in standard deviation can be observed at any end-of-















































a b cΦc end labeling Φc end labeling Φc end labeling
Figure 8.7 | Simulated end-of-labeling triggering at an average heart rate of 40 bpm (blue) and 90 bpm 
(red) with a heart rate variability of 100 ms. a) Relative ASL-signal with triggering. b) Relative ASL-signal 
without triggering (random selection of 33 data points from panel (a)). c) Standard deviation of data 
in panel (a). All values are normalized to the constant flow condition. Error bars indicate the standard 
deviation.
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In-vivo experiments
Physiological parameters as measured during the in-vivo triggered and non-triggered scans are 
provided in Table 8.2. Heart rate (p = 0.31) and mean (p = 0.65) and standard deviation (p = 0.63) 
of the labeling duration did not differ significantly between scans or trigger condition. When 
comparing the phase in the cardiac cycle that we aimed for by setting the post-trigger delay 
with the actual phase at the end-of-labeling, a close correspondence is found (Table 8.2). The 
combination of triggering and set delay showed little variation around the intended cardiac 
phase (5% at longest tested delay (c)). 
The mean gray matter CBF was 55.34±21.21, 53.81±18.85 and 55.80±18.78 ml/100g/min for the 
triggered conditions a,b, and c and 54.19±19.37 ml/100g/min for the non-triggered scan. No 
difference in mean CBF between the four conditions could be detected (p = 0.58, Friedman’s test), 
see Figure 8.8a. The temporal standard deviation of the CBF (13.59±5.04, 14.79±4.23, 15.60±5.38 
and 15.04±6.31 ml/100g/min) was comparable between the four conditions (p = 0.44), see Figure 
8.8b. 
Table 8.2 | Physiological values in-vivo experiment
a) b) c) NT p-value
Heart rate (bpm) 59±8 59±8 59±8 62±11 0.08
Label duration (ms) 7517±97 7492±140 7475±123 7455±7 0.65
Label duration tSTD (ms) 311±95 284±66 324±74 0.63
Set delay (ms) 70±0 418±78 576±82
Cardiac phase (0–1)
End-of-labeling 0.07±0.01 0.40±0.06 0.55±0.07 0.70±0.20
End-of-labeling tSTD 0.01±0.00 0.03±0.01 0.05±0.02 0.20±0.01
Imaging 0.71± 0.19 0.03±0.21 0.83±0.22 0.68±0.17 0.78
Imaging tSTD 0.11±0.02 0.13±0.02 0.14±0.03 0.20±0.01 0.54
Values are Mean±STD. tSTD is the temporal standard deviation over 20 dynamics. p-value indicates the repeated-measures 
ANOVA comparison between the four conditions.
DISCUSSION
The present study investigated the effect of the cardiac cycle on pCASL and especially focused 
on the effect of end-of-labeling triggering on ASL-signal stability. Simulations showed a clear, 
although small (on the order of 4% of the ASL-signal) influence of flow pulsations on the ASL-signal, 
even when the labeling duration spanned multiple cardiac cycles. The timing of the pulsatile flow 
was shown to influence both the generation- and delivery of the label, and the resulting effect 
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Figure 8.8 | In-vivo measurements of mean gray matter CBF and tSTD of the triggered and non-triggered 
scans. tSTD is the temporal standard deviation over 20 dynamics. The moment of end-of-labeling in the 
cardiac cycle a), b) & c) was defined by a set delay and cardiac triggering of the end-of-labeling. The 
cardiac phase of end-of-labeling varied randomly during the non-triggered scan (NT). Removing the 
potential outlier (green triangles) reduced the mean CBF to 48.5±8.4 ml/100 g/min, without effect on 
statistical inferences. 
on the ASL-signal was most associated with the end-of-labeling phase. However, the in-vivo 
experiments could not detect a difference in mean ASL-signal or temporal ASL-signal stability 
between the cardiac phases of the end-of-labeling triggering and/or with the non-triggered scan.
This study aimed to investigate the influence of the cardiac cycle on pCASL measurements of CBF, 
particularly during the end-of-labeling, since that timing will affect the ASL-signal stability most. 
To isolate the influence of cardiac cycle during the end-of-triggering on ASL-signal stability, an 
impractical long labeling duration was employed and combined with end-of-labeling triggering: 
by using these very long labeling durations (>7 s) in the in-vivo experiment, the occurrence of 
additional labeling of e.g. 1 second had little influence on the overall signal as was confirmed 
by the simulations (see Figure 8.6). When translating this to practical scan properties, triggering 
the end-of-labeling could be a candidate approach to minimize signal instabilities due to the 
cardiac cycle, although it might introduce more unwanted effects than solving when employed 
with commonly employed labeling durations. For instance, at typical heart rate of 60 bpm the 
additional labeling duration could vary up to 1 second, therefore the ASL-signal change due to 
the volume of additionally generated label at 2.8 s compared to 1.8 s labeling, could overshadow 
the potential effect of increased signal stability due to end-of-labeling triggering, while greatly 
complicating the consistency of CBF quantification. To provide equal quantitative CBF-estimation 
over such a wide range of labeling durations, it would be crucial to have an accurate estimate 
of dispersion of the bolus of labeled spins [4] and the exact exchange time of the label from the 
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intra- to the extravascular compartment [14], which are both difficult to estimate in an individual 
subject. Therefore, the present study aimed first to study how large the effect of the cardiac cycle is 
on the signal stability, focusing thereby on the potential benefit and properties of end-of-labeling 
triggering before moving to solving all the implementation issues that would be encountered 
when using such an approach in practical clinical applications. The simulation and in vivo results 
suggest, however, that implementing end-of-labeling triggering does not provide important 
improvements in signal stability for most pCASL applications. Therefore, it was not deemed useful 
to solve the aforementioned implementation challenges. It should be noted that during the in 
vivo experiments, only the label condition was end-of-labeling triggered, whereas the following 
control condition was acquired with the same ‘labeling’ duration. Hence the repetition time (TR) 
was the same for each label and control pair, thereby avoiding that magnetization differences 
would affect pair-wise subtractions. Even when controlling for these confounding effects, no 
improvement in signal stability could be proven in the present in-vivo study when using end-of-
labeling triggering. 
The simulations in the present study showed that signal fluctuations due to cardiac pulsations 
range between -8% and +5%. Previous work with simulations of continuous ASL showed a similar 
±5% range in signal variation for a labeling duration of 1500 ms (see Figure 8.7 of reference [4]). 
However, their simulations (convolution of the velocity curve with the Buxton model) only took 
the effects into account that occurred while generating the label. Variation in the transport time 
of the label due to the cardiac cycle was not part of that continuous ASL study, although it was 
included in other studies, which investigated pulsed ASL [5,15-17]. Both modeling and in-vivo 
pulsed ASL data showed earlier arrival of the label with the systolic phase compared to the 
diastolic phase [5,15-17]. The simulations of the present study extent this concept to pCASL and 
showed that the delivery of label enhanced the signal fluctuations of labeling generation. In other 
words, the changes in transport-times during the PLD due to cardiac fluctuations augment the 
ASL-signal increases and decreases caused by flow pulsations during labeling. Hence, the range 
in signal variations of the present simulations is slightly larger than earlier predicted in literature. 
Moreover, this study is the first to show that these signal fluctuation are largely dependent on 
the phase of end-of-labeling and not to the start-of-labeling. Finally, the influence of the cardiac 
cycle on the ASL-signal due to the changed transport times and the differences in the amount of 
generated label, were both greater than changes due to the velocity dependency of the labeling 
efficiency, which is often cited as a major concern in pCASL. 
In the simulations we quoted the influence of the cardiac cycle on ASL-signal by stating the 
observed signal range (-8 to +5%) to illustrate the maximum range of expected ASL-signal 
intensities, however, it could also have been expressed as temporal (tSTD), which has the 
advantage that it can be measured reliably in-vivo. The tSTD of the simulated untriggered case 
was 4% at the lowest heart rate, which in the simulations reduced to 0.08% tSTD when end-of-
labeling triggering was employed. The relative small effect of 4% shows that influence of the 
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cardiac cycle is probably only a minor factor of observed ASL-signal fluctuations. Therefore, other 
physiological factors, such as respiration, might play a bigger role in pCASL [6,18]. 
In the present study, the average coefficient of variation measured in the non-triggered scan 
coefficient of variation was 28±11% and therefore the number of subjects in the present study 
can be considered to be too small to be able to show a 4% difference in temporal STD. However, 
the number of participants was chosen on the ability to proof significant impact on single subject 
pCASL experiments. When the effect of end-of-triggering could not be proven in a group of 
eight subjects, it is clear that the total effect of cardiac pulsations can be considered minor in 
pCASL. Taken together, the simulations and in-vivo experiments suggest that the effect of cardiac 
pulsations is small and triggering the end-of-labeling (and therefore also the start-of-triggering) 
provides no consistent improvement in ASL-signal stability on a per-subject basis.
Other methods, besides cardiac triggering, have also been proposed to reduce noise in ASL. 
Background suppression pulses have been shown to improve the general ASL-signal stability 
independent of cardiac pulsations [6]. Background suppression is particularly effective when using 
a read-out option with a single excitation pulse such as 3D-GRACE or 3D FSE stack-of-spirals [1]. 
Application of background suppression in the present study was not included, because of the high 
implementation complexity due to the varying TR of each label-control pair. Physiological noise 
reduction can also be achieved during post-processing, for example by using RETROICOR [6,18] 
By design, RETROICOR includes the cardiac and respiratory regressor determined at the moment 
of imaging into account, whereas the influence of the cardiac cycle at the start-of-labeling or end-
of-labeling was not considered [4,6,18]. Application of RETROICOR in the present study proofed 
of limited value due to the low number of dynamics for each condition (20 label-control pairs) 
and was therefore omitted from the final analysis. Although these post-processing techniques 
provide a consistent way to reduce (physiological) noise from ASL, it would be beneficial when 
these noise-sources would be suppressed during the acquisition of the signal. As an extreme 
variant of triggered ASL, we considered and tested “triple triggered” pCASL (triggering the start- 
and the end-of-labeling as well as the moment of imaging), which would appear to be more in 
line with physiology than the independent chosen values as currently employed. Triple triggered 
ASL leads, however, to ASL-signals that are mainly proportional to the duration cardiac cycle, and 
should therefore be considered to be not very informative.
The present study modeled the arterial compartment as a rigid vessel without compliance. Arterial 
compliance is an important mechanical property that gradually reduces the flow pulsatility along 
the arterial tree toward the tissue compartment. Generation of label at the proximal end of the 
artery is governed by the typical flow curve (Figure 8.1), which already included the compliance 
of the arterial tree. The delivery of the label to the tissue was shown in the present study to play a 
minor role compared to generation. Compliance decreases the flow pulsatility during the delivery 
phase, which would in turn reduce variations in delivery time and thus increase overall signal 
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variability. Therefore, the assumption of rigid arterial compartment can be considered to provide 
a ‘worst-case’ scenario for the influence of flow pulsations.
The present study used the build-in finger pulse-oxy triggering of the MRI-scanner to synchronize 
the end-of-labeling with the cardiac cycle, which always lags behind in time compared to ECG-
triggering. The present simulations suggest that the optimal moment of triggering lies at the end-
systolic phase which corresponds to the finger pulse-oxy trigger with a delay of 0 ms. Although 
ECG triggering would allow more flexibility in choosing end-of-labeling phases within the systole, 
the practical application of finger triggering in the present study can be expected not to have 
influenced the accuracy (see Table 8.2) of the end-of-labeling triggering. 
CONCLUSIONS
In summary, simulations showed that flow pulsations can influence the ASL-signal by approximately 
4%, and that especially the cardiac cycle at the end-of-labeling is of importance. However, in-vivo 
experiments provided no difference in mean signal and/or signal stability. Combined with earlier 
findings concerning cardiac triggering, neither start-of-labeling nor end-of-labeling triggering 
improves signal stability significantly, suggesting that cardiac triggering is not very beneficial 
for pCASL. Post-processing methods that include cardiac and/or other physiological regressors 
(including the timing at the end-of-labeling) could be considered to correct most of the remaining 
minor influences of the cardiac cycle on pCASL stability.
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The brain is a metabolically active organ with little capacity for energy storage. This makes it 
highly dependent on a continuous supply of nutrients and oxygen. Multiple control mechanisms 
protect the brain against hypo- and hyperperfusion, which is so efficacious that the brain is often 
considered a hemodynamically separate entity from the rest of the body. 
Despite these protective mechanisms, it is known that patients with cardiac dysfunction have a 
higher prevalence of cognitive dysfunction and higher risk of incident dementia and Alzheimer’s 
disease. Fortuitously, the unfavorable effects of cardiovascular dysfunction on the brain seem 
reversible as improvement of cardiac function (for example cardiac transplantation or cardiac 
resynchronization treatment) restores brain perfusion and improves cognition. This suggests a 
new preventive and therapeutic target for improving cognition by ensuring blood supply to the 
brain based on improving cardiac function. Not only diseases of the heart are associated with loss 
of cognitive function, but diseases of the brain can also affect cardiac function. This bidirectional 
interrelationship is known under the term: heart-brain axis. 
Understanding the heart-brain relation might guide future treatment decisions and give incentive 
for novel therapy development. The primary aim of the project “Go with the flow: the heart-brain 
axis” was to elucidate the interaction between heart and the brain, across the lifespan. This was 
done by integration of physiological concepts into the MRI-environment and by monitoring brain 
perfusion and its regulatory mechanisms at both the macrovascular level (using transcranial 
Doppler) and the tissue level (using arterial spin labeling MRI). This thesis focused mainly on the 
comparison and validation of these two modalities used in this project. Expertise from both the 
fields of cardiovascular physiology and MRI brain perfusion measurements were integrated into 
synergistic and comprehensive research protocols. 
Chapters 1–3 provide a general introduction on the heart-brain axis, offer an overview of 
the underlying physiology, employed methodologies, and the physiological challenges and 
techniques applied in this project.
In chapters 4, 5 & 6, we considered the trustworthiness of the general assumption of middle 
cerebral artery diameter constancy. This assumption is applied to relate the TCD-measured 
cerebral blood flow velocity (CBFv) changes to changes in cerebral blood flow (CBF), i.e. brain 
perfusion changes. We applied high resolution MRI at 7 Tesla to investigate the middle cerebral 
artery (MCA) diameter during various environmental challenges. In chapter 4, we manipulated 
the end-tidal CO2 concentration and showed that the MCA diameter increased at high levels 
of end-tidal CO2. In chapter 5, high-resolution images of the MCA were obtained synchronized 
with the cardiac cycle. We found a subtle increase in MCA diameter during systole compared 
to diastole, suggesting that the diameter is sensitive to the pressure changes that occur within 
the heartbeat. Subsequently, in chapter 6, the effect of handgrip exercise on the MCA diameter 





cerebral macrovasculature. These studies challenge the long-held assumption of MCA diameter 
constancy. 
In chapter 7, we compared the CBFv response to rhythmic handgrip exercise in the MCA (measured 
by TCD) to the CBF response in the MCA flow territory (assessed with arterial spin labeling MRI 
(ASL)). Differences in arterial blood flow velocities are often used as proxy for changes in flow and 
brain tissue perfusion. We found that during rhythmic handgrip the CBFv increased, whereas no 
change in the MCA flow territory could be observed. Therefore, whole-brain CBF-measurements 
by ASL do not support the claim that a change in MCAv measured by TCD can be used as a proxy for 
regional CBF during rhythmic handgrip exercise. The observed decrease in MCA diameter during 
handgrip as observed in chapter 6 can only explain a small part (approximately one fifth) of the 
observed discrepancy. Shunting of MCA blood flow during exercise (i.e. not feeding the brain 
tissue) could explain this discrepancy; however, evidence for such a hypothesized mechanism 
is currently lacking. Implications for understanding the underlying physiological mechanisms 
could be far reaching for either one or both modalities, indicating the need to further explore the 
relation of arterial blood flow and tissue perfusion.
In chapter 8, we investigated the influence of cardiac pulsations on pseudo-Continuous ASL 
(pCASL) signal stability. Due to the long labeling duration in pCASL the relative contribution of 
the label created at the end of labeling to the detected ASL-signal will be the largest, while this 
could be highly dependent on the moment of the cardiac cycle when labeling stops. Simulations 
showed only modest influence of the cardiac cycle, with variations both originating from the 
amount of label created at the end-of-labeling as well as from different transport times of the label 
to the imaging region during the post-labeling delay. An end-of-labeling triggering scheme was 
implemented on the scanner to validate these simulation-findings. In-vivo human experiments 
did also not show measurable effects of triggering on the ASL-signal intensity or stability. 
Combined with earlier studies on cardiac triggering, it was concluded that cardiac triggering at 
the start or the end of labeling has little benefit to pCASL signal stability. 
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The studies presented in this thesis laid further groundwork for integrative and multi-disciplinary 
studies of the Rembrandt Project “Go with the Flow” and the heart-brain connection in general. 
At the core of the Rembrandt project is the multi-disciplinary approach. This approach allowed 
us to challenge existing dogma in TCD as measure for cerebral blood flow changes and create new 
opportunities for future research with Lower Body Negative Pressure in the MRI. These topics will be 
discussed in the next paragraphs. 
TCD AS MEASURE FOR CEREBRAL BLOOD FLOW CHANGES
The non-invasive nature of TCD, together with its high temporal resolution, portability and 
affordable setup has made it into a widely-used research and clinical tool [1]. Since the 
introduction of TCD [2] three decades ago the few basic assumptions of TCD, that couple velocity 
measurements to cerebral blood flow, have been continuously under discussion [3]. In this thesis, 
we have aimed to validate two important aspects of TCD: assumption of diameter constancy and 
whether TCD reflects cerebral blood flow changes. 
The first aspect, diameter constancy, assumes that the diameter of the vessel that is insonated by 
TCD remains constant during physiological challenges. Earlier studies have directly and indirectly 
measured diameter changes, see e.g. a recent editorial on this topic [3]. In this thesis, we showed 
with high resolution MRI that this assumption does not hold up during challenges such as: high 
levels of hypercapnia (chapter 4), systolic-diastolic pressure differences (chapter 5) and rhythmic 
handgrip exercise (chapter 6). However, these modulations of the velocity are small when 
compared to differences that are considered clinically relevant. For example, in stroke patients 
the difference in (TCD measured) cerebrovascular reactivity at three months follow-up between 
two patient cohorts was approximately 30% [4]. The diameter change observed in our studies 
would account for approximately one fifth of those CBF-changes as predicted from velocity 
measurements by TCD, thus potentially overestimating (or underestimating) the differences 
between groups rather than within groups. This thesis challenges the long-held assumption 
of diameter constancy, which obscures the interpretation of experimental data as well as the 
(comparison of ) different responses between groups, e.g. patient cohorts.
Measurements obtained with TCD are often interpreted as changes in CBF, i.e. tissue perfusion. 
TCD is often used to probe CBFv changes at the level of the Circle of Willis, hence obtaining an 
aggregated measurement over the entire flow territory of the insonated vessel. In chapter 7 we 
showed that during handgrip exercise, the ASL CBF did not increase in the flow territory, whereas 
the TCD CBFv increased by 10% in the corresponding artery. When looking into more detail the 
ASL determined CBF appeared to increase more locally in the precentral region (motor cortex). 
This is too small a region to trigger a detectable increase in the mean total MCA flow territory 
CBF, attributed to neural activation. The expected change in CBFv extrapolated from such a 
small region (1.5%) still remains within the detection limit of TCD, which is approximately 1% 
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(unpublished pilot data). However, the change as measured with TCD (10%) overestimates the 
change as determined with ASL by one order of magnitude. Although, as also stated in the 
previous paragraph, we did show that during handgrip exercise the MCA-diameter changes 
significantly (2% area change, chapter 6), this is much smaller than the velocity difference (10%). 
Previous TCD studies have shown significant changes in MCA-velocity occur following emotional 
or sensory stimulation [1,5], and that hemispheric dominance of hand movement originating in 
small cortical regions can be detected [6,7]. These results illustrate that TCD does detect velocity 
changes in response to cognitive or motor challenges, it is as yet uncertain whether these are 
exclusively related to changes in local or global CBF or whether diameter changes also explains 
some of these detected velocity changes. This discrepancy between large artery blood flow and 
tissue perfusion raises fundamental questions (see chapter 7) for which present literature does 
not provide straightforward explanations. 
With respect to the question whether we can still apply TCD to measure CBF changes, the results of 
the present thesis seem to be very clear: i.e. TCD velocity changes are not always a valid proxy for 
CBF changes at the tissue level for two reasons. First, during physiological challenges constancy 
of vessel diameter cannot always be assumed, which introduces a level of bias and uncertainty 
in the TCD determined “perfusion” responses. Second, the coarse spatial resolve TCD obscures 
localized changed in CBF, and unlikely reflects focal changes in tissue perfusion. This should, 
however, not be considered as a rejection of TCD for physiological brain research, but more as a 
strong call to first elucidate these inconsistencies to avoid that misinterpretations on (the control 
of ) cerebral perfusion will enter the scientific literature, thereby obscuring the true mechanisms. 
Further research and especially more multi-modality studies that combine the strengths of TCD 
and e.g. ASL-MRI are required to elucidate how cerebral perfusion and blood velocity in large 
cerebral arteries are related. 
LOWER BODY NEGATIVE PRESSURE IN THE MRI
Head-up-tilt (HUT) is the most commonly employed orthostatic challenge for the clinical 
evaluation of patients with syncope of unknown origin [8,9]. Currently, cerebral hemodynamic 
responses to HUT are assessed by TCD, which lacks spatial differentiation. Non-invasive MRI CBF-
measurements using supine LBNP as challenge might provide insight in the underlying neuronal 
activation processes and enable identification of areas of hemodynamic impairment during 
orthostatic stress. 
Applying LBNP in the MRI is a challenge, both for practical and safety reasons. A practical concern 
is that subject motion during the application of pressure during LBNP is inevitable. Such motion 
occurs in sync with the applied stimulus, i.e. both motion- and stimulus effects overlap each other 
in time. This creates ambiguity as to whether the measured data reflect an effect of LBNP, is the 
result of subject motion, or a mixture of these two. In the context of the Rembrandt Project, we 
519307-L-bw-verbree
108 | Chapter 10
have applied LBNP in the MRI [unpublished data] and observed considerable head movement 
of 1–2 cm (see Figure 10.1). Head motion during LBNP causes large changes in the raw (i.e. 
unsubtracted) ASL-signal (see Figure 10.1a). Post-processing software (e.g. SPM, FSL) can be used 
to correct for head motion. However, the translations and rotations are mostly through-plane 
(z-direction), complicating the post-processing correction due to the relatively large thickness 
of the imaging slices. Moreover, motion-induced signal deviations are mostly non-linear, both in 
(image)-space and time [10], which further complicates corrections by post-processing. Another 
major concern is that (head) motion will also displace the ASL labeling plane with respect to 
subjects’ anatomy, such that changes in artery anatomy, blood velocities, arterial transit time, 
main magnetic field (B0), shimming and coil loading could influence the labeling efficiency and 
the subsequent CBF quantification. Since ASL relies on the subtraction of label and control images, 
the CBF calculation would still remain unaffected as long as label and control conditions are being 
affected by a similar offset in signal intensity. However, due to the effects discussed earlier, this 
is not the case in reality, and the result is large errors in the measurement of the CBF-response 
to LBNP. To remedy the subject motion during LBNP, we built and tested, in collaboration with 
the Instrumental Design Department of the LUMC, a prototype of a compact LBNP box [11]. By 
restricting the area of negative pressure to the pelvic region and the upper-legs, less downward 
force is present during the periods of negative pressure, thereby minimizing motion. Using the 
compact box a strong reduction in head motion was achieved while maintaining similar systemic 
hemodynamic responses. This could prove to be an important step to bring the LBNP research to 
the field of MRI. Finally, another solution would be to repeat the survey scans during the different 
levels of LBNP, to adopt the planning of the ASL scans as well as to repeat the MR-calibration scans 
during these conditions. Whereas this will make the CBF-measurement by ASL less dependent on 
the induced motion, it severely limits the time-efficiency of the study-protocol and might lead to 
unwanted increases in the total time that LBNP is applied.
LBNP in MRI has been used for a variety of experiments, such as assessing muscle metabolism 
using MR spectroscopy [12,13], for performing cardiac MRI [14-16], assessing the diameter of 
the large brain-feeding arteries [17] and for probing autonomic and baroreflex function in 
the brain [18,19]. In the Rembrandt Project, we have applied LBNP to investigate the relation 
between cardiac output and brain perfusion, leading to the observation that subject motion 
during moderate levels of LBNP can adversely affect the obtained measurements of the brain 
[unpublished results]. In contrast, we have successfully applied LBNP in MRI to investigate the 
effect of sympathetic stimulation on renal perfusion [20]. Nevertheless, the potential of LBNP in 
the MRI remains to be proven. 
In the Rembrandt Project we showed [21] that humans differ in their cardiovascular response 
patterns to LBNP that are reproducible over time in one and the same individual. Currently, 
real-time (continuous non-invasive) blood pressure measurements, and especially the derived 
cardiovascular parameters such as stroke volume and peripheral resistance, are not available in 
the MRI environment. This hampers the classification of the underlying cardiovascular response 
519307-L-bw-verbree
109General discussion | 
10
in MRI research. Generally, such real-time cardiovascular monitoring is important for subject 
safety, as sudden changes in blood pressure or heart rate are suggestive of for the occurrence 
of (near) syncope. Therefore, both safety and response classification underline the importance 
of advancing integrative cardiovascular monitoring in an MRI environment, to facilitate correct 
interpretation of the cerebrovascular response within the framework of the human heart-brain 
axis.
Figure 10.1 | Representative MRI signal and head displacement during three consecutive LBNP 
challenges in one subject. a) Global signal for control and label conditions b) Framewise Displacement 
(FD) and absolute translations and rotation; c) Relative Translations along x-, y- and z-axis; z-axis is 
toward the box D) Relative rotations. Global signals are averaged over the entire brain, excluding the 
skull.
CONCLUDING REMARKS
In the Rembrandt Project “Go with the flow”, we have integrated the fields of cardiovascular 
physiology and brain MR imaging to investigate the heart-brain axis, and the fruits of the multi-
disciplinary approach in this thesis have been plentiful. Learning from other fields of expertise 
creates insight and challenges traditional assumptions. In this thesis, we have used MRI to verify 
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an often-debated assumption of TCD (chapters 4–6). Moreover, the cardiovascular physiology 
underscores (to the cerebrovascular MRI community) that the brain does not stop at the neck, 
but has a body than can respond differently to the same LBNP challenge [21]. This underlines the 
importance of implementing continuous cardiovascular monitoring in the MRI-scanner to enable 
the study of the brain and body in an integrated fashion. Also, when bringing physiological 
challenges, such as LBNP, to the MRI-scanner, limitations of MRI become evident, demanding 
multi-disciplinary and creative solutions [11]. Combining fields of expertise in the Rembrandt 
Project has provided fuel to challenge the validity of currently used methods to measure global 
and regional cerebral blood flow during exercise (chapter 7). TCD seems not to reflect changes 
in tissue perfusion, but on the flip-side, ASL-perfusion MRI fails to explain why a large and 
obvious increase in blood velocity is observed in the MCA during exercise. This has far-reaching 
implications for the translation of the concept of cerebral autoregulation (mainly developed 
in the TCD domain) to the field MRI; i.e. both modalities seem to measure different aspects of 
cerebral hemodynamics. The observations in our work challenged existing dogma, and gave 
insight in the assumptions of the employed techniques which contribute to better understanding 
of underlying (patho-)physiological mechanisms. Also, these findings provide a starting point for 
evaluating the integrative response of heart and brain which may help guiding future treatment 
decisions and the development of treatment and interventions strategies in both heart and brain 
dysfunction. 
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De hersenen zijn een metabolisch actief orgaan met weinig capaciteit voor energieopslag. Dat 
maakt de hersenen compleet afhankelijk van een continue toevoer van voedingsstoffen en 
zuurstof. Meerdere reguleringssystemen beschermen de hersenen tegen hypo- en hyperperfusie. 
Deze mechanismes houden de perfusie zo effectief constant dat de hersenen vaak worden gezien 
als een hemodynamisch “los” systeem, separaat van de rest van het lichaam. 
Ondanks deze beschermingsmechanismen is het bekend dat de prevalentie van cognitieve 
dysfunctie in patiënten met cardiale dysfunctie hoger is en dat deze patiënten een hoger risico 
hebben op het ontstaan van dementie en de ziekte van Alzheimer. Gelukkig lijken de ongunstige 
effecten van cardiale dysfunctie op het brein in ieder geval gedeeltelijk reversibel. Verbetering 
van de hartfunctie (door bijvoorbeeld transplantatie of resynchronisatietherapie) herstelt zowel 
hersenperfusie alsmede het cognitief functioneren. Dit geeft een mogelijk nieuw therapeutisch 
perspectief voor het herstel van cognitieve functie: zorgen voor adequate hersendoorbloeding 
door de hartfunctie te verbeteren, bijvoorbeeld door medicatie. Niet alleen ziektes van het hart 
zijn geassocieerd met verminderde cognitieve functie, maar ziektes van het brein kunnen ook 
de functie van het hart beïnvloeden. Deze bi-directionele relatie wordt wel de “hart-brein as” 
genoemd.
Inzicht in de “hart-brein as” zou in de toekomst behandelbeslissingen kunnen ondersteunen 
en aanzet geven tot ontwikkeling van innovatieve therapieën. De primaire doelstelling van 
het project “Go with the flow: the heart-brain axis” is het ontrafelen van de interactie tussen 
het hart en het brein en de veranderingen hierin gedurende de levensduur. Door fysiologische 
concepten te integreren in de magnetische resonantie (MRI) scanner krijgen we gelijktijdig 
toegang tot hersenperfusie en de mechanismen die de hersenperfusie regelen en beïnvloeden. 
De hersenperfusie kan zowel op weefselniveau (met transcraniële Doppler buiten de MRI) als op 
microvasculair niveau (met arteriële spin labeling MRI) gemeten worden. Dit proefschrift richt 
zich op het vergelijken en valideren van deze twee modaliteiten. Om dit doel te bereiken worden 
cardiovasculaire fysiologische en MRI-hersenperfusie technieken geïntegreerd in uitgebreide 
synergistische onderzoeksprotocollen.
Hoofdstukken 1–3 geven een algemene introductie op de “hart-brein as”, de onderliggende 
fysiologie en de gebruikte (fysiologische) methoden en technieken.
In hoofdstukken 4, 5 & 6 wordt de geldigheid onderzocht van de algemeen gebruikte 
aanname dat de mediale cerebrale arterie (MCA)-diameter constant blijft tijdens fysiologische 
veranderingen. Deze aanname is voornamelijk van toepassing op het vertalen van TCD-gemeten 
veranderingen in bloedstroomsnelheid (CBFv) naar bloedvolumestroom (CBF) (ook bekend onder 
de naam hersenperfusie). Om deze aanname te testen, is gebruik gemaakt van hoge resolutie 
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7 Tesla MRI om veranderingen in de MCA-diameter te bepalen tijdens een aantal fysiologische 
manoeuvres. In hoofdstuk 4 wordt de eindexpiratoire CO2 concentratie gevarieerd en laten we 
zien dat bij hogere concentraties CO2 de MCA-diameter toeneemt. In hoofdstuk 5 onderzochten 
we de invloed van bloeddruk op de MCA-diameter door hoge resoluties MRI opnames van de 
MCA te synchroniseren met de hartslag. Hierbij werd een subtiele toename in MCA-diameter 
tijdens de systole gevonden in vergelijking met de diastole. Vervolgens hebben we in hoofdstuk 
6 het effect van ritmisch knijpen van de hand op de MCA-diameter bepaald. We laten zien dat 
door ritmisch knijpen een kleine afname in diameter wordt veroorzaakt, wat indicatief is voor 
sympathische invloed op de grote hersenvaten. Deze studies dagen de lang-bestaande aanname 
van constante MCA-diameter uit.
In hoofdstuk 7 vergelijken we de CBFv response in de MCA gemeten met TCD tijdens ritmisch 
knijpen van de hand met de respons op dezelfde taak gemeten met ASL in het stroomgebied 
van de MCA. Verschillen in CBFv worden vaak gebruikt als plaatsvervangend equivalent voor 
veranderingen in bloedstroomvolume en hersenperfusie. We vonden dat volgens TCD de 
CBFv sterk toenam tijdens ritmisch knijpen, maar dat er door ASL geen veranderingen in CBF 
gedetecteerd werd in het MCA-stroomgebied. Deze metingen ondersteunen daarom niet de 
aanname dat CBFv een plaatsvervangend equivalent is voor regionale CBF-veranderingen. 
Een afname in MCA-diameter tijdens ritmisch knijpen, zoals gemeten in hoofdstuk 6, kan maar 
een klein deel (ongeveer één vijfde) verklaren van de discrepantie. Shunts die het bloed om 
de hersenen heen leiden zouden dit fenomeen kunnen verklaren, maar voor deze hypothese 
ontbreekt vooralsnog sluitend bewijs. Implicaties voor het begrijpen van de onderliggende 
fysiologische mechanismen kunnen verstrekkend zijn voor één of zelfs voor beide modaliteiten. 
Dit geeft aan dat verder onderzoek nodig is om de relatie tussen bloedstroom in de grote vaten 
en hersenperfusie op weefselniveau te beschrijven.
In hoofdstuk 8 wordt de invloed van pulsaties van het bloed op de stabiliteit van het pCASL 
signaal bestudeerd. Door de lange labelingsduur in pCASL is de relatieve bijdrage van het bloed 
dat als laatste gelabeld is aan het pCASL signaal het grootst. Onze simulaties laten een kleine 
invloed zien van de fase van de hartcyclus aan het einde van de labelperiode op het ASL-signaal. 
Deze invloed wordt veroorzaakt door zowel variaties in de hoeveelheid gelabelde bloed dat op 
het laatst gegenereerd wordt als door (kleine) variaties in transporttijd van het label naar het 
afbeeldingsgebied tijdens de “post labeling delay”. In-vivo experimenten met speciale pCASL 
hartslag-synchronisatie techniek laten geen meetbaar effect zien van de hartslag-fase op de 
signaalstabiliteit. We concluderen, mede op basis van eerdere literatuur, dat het synchroniseren 
van de start of einde van het labelen met de hartslag weinig toegevoegde waarde heeft voor de 
signaal stabiliteit van pCASL.
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